,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-1799339,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,52/331,108/8183,2.09186245370429e-44,1.97053443138944e-41,1.57440174147217e-41,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/SSR4/RPL29/RPS28/RPL3/RPL14/RPL26/SEC61G/RPL24/RPS29/RPL36/RPL34/SPCS1/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/SEC11C/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPN1/RPS15A/SEC11A/DDOST/SRP9/RPL4/RPS9/RPS20/RPS14/RPLP1,52
R-HSA-156902,R-HSA-156902,Peptide chain elongation,45/331,85/8183,7.14118270567402e-41,3.36349705437246e-38,2.68733980766154e-38,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/EEF2/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,45
R-HSA-156842,R-HSA-156842,Eukaryotic Translation Elongation,45/331,89/8183,1.11600674810736e-39,2.62819589179284e-37,2.0998548023599e-37,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/EEF2/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,45
R-HSA-72764,R-HSA-72764,Eukaryotic Translation Termination,45/331,89/8183,1.11600674810736e-39,2.62819589179284e-37,2.0998548023599e-37,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/TRMT112/RPLP1,45
R-HSA-192823,R-HSA-192823,Viral mRNA Translation,44/331,85/8183,2.13704546785812e-39,4.02619366144469e-37,3.21681580951274e-37,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-2408557,R-HSA-2408557,Selenocysteine synthesis,44/331,89/8183,3.04157880801781e-38,4.77527872858796e-36,3.81531376795216e-36,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-156827,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,47/331,107/8183,8.69785389712519e-38,1.1704826244417e-35,9.35182787435265e-36,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/EIF4A2/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/EIF4A1/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,47
R-HSA-975956,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),44/331,91/8183,1.07375878658345e-37,1.26435097120201e-35,1.01018096369364e-35,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-72706,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,47/331,108/8183,1.48698244280908e-37,1.52392124435964e-35,1.21757033156458e-35,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/EIF4A2/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/EIF4A1/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,47
R-HSA-72689,R-HSA-72689,Formation of a pool of free 40S subunits,45/331,97/8183,1.6177507901907e-37,1.52392124435964e-35,1.21757033156458e-35,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,45
R-HSA-72613,R-HSA-72613,Eukaryotic Translation Initiation,47/331,115/8183,5.25953801593627e-36,4.12873734250998e-34,3.29874533455652e-34,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/EIF4A2/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/EIF4A1/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,47
R-HSA-72737,R-HSA-72737,Cap-dependent Translation Initiation,47/331,115/8183,5.25953801593627e-36,4.12873734250998e-34,3.29874533455652e-34,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/EIF4A2/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/EIF4A1/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,47
R-HSA-2408522,R-HSA-2408522,Selenoamino acid metabolism,46/331,113/8183,3.7650313816815e-35,2.72819966272613e-33,2.17975501044718e-33,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/EEF1E1/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1/EPRS,46
R-HSA-9010553,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,52/331,162/8183,1.34510450471244e-33,9.05063173885086e-32,7.23120090879245e-32,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/PSMB9/PSMB8/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/PSMD6/RPL17/ELOB/RPL28/RPL22L1/RPS26/RPS23/RPS25/PSMD7/RPS15A/RPL4/RPS9/RBX1/RPS20/RPS14/RPLP1/PSME1/UBC,52
R-HSA-376176,R-HSA-376176,Signaling by ROBO receptors,57/331,205/8183,4.89162114260319e-33,2.71604972413807e-31,2.17004755029469e-31,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RHOA/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/PFN2/PSMB9/PSMB8/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/PSMD6/RPL17/ELOB/RPL28/CDC42/RPL22L1/RPS26/RPS23/RPS25/PSMD7/RPS15A/RAC1/RPL4/RPS9/RBX1/PFN1/RPS20/RPS14/RPLP1/PSME1/UBC,57
R-HSA-927802,R-HSA-927802,Nonsense-Mediated Decay (NMD),44/331,111/8183,4.90157593528102e-33,2.71604972413807e-31,2.17004755029469e-31,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-975957,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),44/331,111/8183,4.90157593528102e-33,2.71604972413807e-31,2.17004755029469e-31,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-168255,R-HSA-168255,Influenza Life Cycle,48/331,139/8183,1.03931797185416e-32,5.43909738603676e-31,4.34568625658317e-31,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/CALR/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/HSPA1A/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/HSPA1B/RPL41/RPL21/POLR2H/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,48
R-HSA-168254,R-HSA-168254,Influenza Infection,49/331,149/8183,3.12197074859206e-32,1.54784023430196e-30,1.23668093365281e-30,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/CALR/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/HSPA1A/RPS18/RPSA/RPS17/SLC25A6/RPL35/RPL27A/RPS16/RPL31/HSPA1B/RPL41/RPL21/POLR2H/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,49
R-HSA-168273,R-HSA-168273,Influenza Viral RNA Transcription and Replication,45/331,129/8183,6.59394740639266e-31,3.10574922841094e-29,2.48140652398461e-29,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/POLR2H/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,45
R-HSA-72766,R-HSA-72766,Translation,61/331,287/8183,3.08044290936863e-28,1.38179867648822e-26,1.10401838606445e-26,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/SSR4/RPL29/RPS28/RPL3/RPL14/RPL26/SEC61G/RPL24/RPS29/RPL36/RPL34/EIF4A2/SPCS1/RPL32/RPL27/RPLP2/RPS19/EEF2/RPL39/RPS18/RPSA/RPS17/EIF3L/RPL35/RPL27A/RPS16/RPL31/SEC11C/RPL41/RPL21/EIF4A1/RPL17/MRPL33/RPL28/EEF1E1/RPL22L1/RPS26/RPS23/RPS25/RPN1/RPS15A/SEC11A/DDOST/SRP9/RPL4/RPS9/MRPS26/RPS20/RPS14/TRMT112/RPLP1/EPRS,61
R-HSA-5663205,R-HSA-5663205,Infectious disease,63/331,362/8183,4.42512103668293e-24,1.89475637116151e-22,1.51385719675995e-22,RPS21/RPL37A/RPL36A/B2M/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/CD9/CALR/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/EEF2/RPL39/HSPA1A/RPS18/RPSA/PSMB9/PSMB8/RPS17/SLC25A6/RPL35/RPL27A/ELMO1/RPS16/RPL31/HSPA1B/RPL41/RPL21/POLR2H/PSMD6/RPL17/ELOB/RPL28/RPL22L1/RPS26/RPS23/RPS25/PSMD7/RPS15A/RAC1/RPL4/RPS9/RBX1/RPS20/AP2M1/RPS14/RPLP1/PSME1/UBC,63
R-HSA-6791226,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,44/331,179/8183,3.77513992841413e-23,1.54616600546353e-21,1.23534327176938e-21,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/RPLP1,44
R-HSA-8868773,R-HSA-8868773,rRNA processing in the nucleus and cytosol,45/331,189/8183,4.82130421207752e-23,1.89236190324043e-21,1.51194408405063e-21,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/TRMT112/RPLP1,45
R-HSA-422475,R-HSA-422475,Axon guidance,72/331,498/8183,1.60916708036722e-22,6.06334155882369e-21,4.84443984194764e-21,RPS21/TUBB2B/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RHOA/RPL29/RPS28/RPL3/RPL14/RPL26/CD24/RPL24/RPS29/TUBA1A/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/TUBB2A/RPSA/PFN2/PSMB9/PSMB8/RPS17/TUBB3/MYL6/RPL35/RPL27A/RPS16/RPL31/RPL41/RET/RPL21/PSMD6/RPL17/MYL12B/ELOB/RPL28/CDC42/RPL22L1/RPS26/RPS23/RPS25/PSMD7/ALCAM/RPS15A/RAC1/DPYSL3/RHOB/RPL4/RPS9/NCSTN/RBX1/PFN1/RPS20/AP2M1/RPS14/HRAS/RPLP1/PSME1/TUBB4B/UBC,72
R-HSA-71291,R-HSA-71291,Metabolism of amino acids and derivatives,57/331,320/8183,2.67888097542343e-22,9.70579184172642e-21,7.75465545517308e-21,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/OAZ1/PCBD1/RPSA/PSMB9/PSMB8/RPS17/TPH1/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/PSMD6/RPL17/RPL28/EEF1E1/RPL22L1/RPS26/RPS23/RPS25/PSMD7/PDHB/RPS15A/RPL4/RPS9/ADI1/RPS20/RPS14/RPLP1/EPRS/PSME1/SRM,57
R-HSA-72312,R-HSA-72312,rRNA processing,45/331,198/8183,3.76782866980396e-22,1.3145535581316e-20,1.05029142257693e-20,RPS21/RPL37A/RPL36A/RPS10/RPS27/RPL13/RPL37/RPL38/RPL15/RPL29/RPS28/RPL3/RPL14/RPL26/RPL24/RPS29/RPL36/RPL34/RPL32/RPL27/RPLP2/RPS19/RPL39/RPS18/RPSA/RPS17/RPL35/RPL27A/RPS16/RPL31/RPL41/RPL21/RPL17/RPL28/RPL22L1/RPS26/RPS23/RPS25/RPS15A/RPL4/RPS9/RPS20/RPS14/TRMT112/RPLP1,45
R-HSA-72649,R-HSA-72649,Translation initiation complex formation,20/331,57/8183,2.41408257478129e-14,7.84160615670336e-13,6.26522337919645e-13,RPS21/RPS10/RPS27/RPS28/RPS29/EIF4A2/RPS19/RPS18/RPSA/RPS17/EIF3L/RPS16/EIF4A1/RPS26/RPS23/RPS25/RPS15A/RPS9/RPS20/RPS14,20
R-HSA-72702,R-HSA-72702,Ribosomal scanning and start codon recognition,20/331,57/8183,2.41408257478129e-14,7.84160615670336e-13,6.26522337919645e-13,RPS21/RPS10/RPS27/RPS28/RPS29/EIF4A2/RPS19/RPS18/RPSA/RPS17/EIF3L/RPS16/EIF4A1/RPS26/RPS23/RPS25/RPS15A/RPS9/RPS20/RPS14,20
R-HSA-72662,R-HSA-72662,Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S,20/331,58/8183,3.55083048323992e-14,1.11496077173733e-12,8.9082238439177e-13,RPS21/RPS10/RPS27/RPS28/RPS29/EIF4A2/RPS19/RPS18/RPSA/RPS17/EIF3L/RPS16/EIF4A1/RPS26/RPS23/RPS25/RPS15A/RPS9/RPS20/RPS14,20
R-HSA-72695,R-HSA-72695,Formation of the ternary complex, and subsequently, the 43S complex,18/331,50/8183,2.95545164056792e-13,8.98075950133864e-12,7.17537495078459e-12,RPS21/RPS10/RPS27/RPS28/RPS29/RPS19/RPS18/RPSA/RPS17/EIF3L/RPS16/RPS26/RPS23/RPS25/RPS15A/RPS9/RPS20/RPS14,18
R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,43/331,379/8183,5.12251717368532e-10,1.50794099300362e-08,1.20480255894244e-08,B2M/HLA-C/HLA-B/RHOA/FTH1/FABP5/NPC2/VAMP8/CYBA/EEF2/CD63/MME/HSPA1A/PSAP/CSTB/DPP7/GRN/GSTP1/GYG1/HSPA1B/LAMP1/HSPA6/GGH/SVIP/PSMD6/HEXB/PRDX4/CD47/PSMD7/RAB7A/DSP/DYNLL1/DDOST/RAC1/NME2/NCSTN/NDUFC2/BRI3/AGPAT2/RNASET2/MIF/APRT/TUBB4B,43
R-HSA-163200,R-HSA-163200,Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,20/331,110/8183,1.23286266349427e-08,3.51926251215638e-07,2.81179203954834e-07,ATP5F1E/NDUFAF3/NDUFA13/NDUFA11/COX7C/UQCR11/NDUFB4/NDUFB5/COX4I1/ATP5PO/NDUFB1/COX6C/UQCR10/NDUFA3/UQCRC1/NDUFC2/ATP5ME/NDUFA6/UQCRFS1/NDUFS5,20
R-HSA-8953897,R-HSA-8953897,Cellular responses to external stimuli,45/331,470/8183,4.23140052790777e-08,1.17234685214386e-06,9.36672253081752e-07,TUBB2B/TOMM7/TUBA1A/HIST1H4C/CA9/CYBA/HSPA1A/TUBB2A/HIST1H1C/PSMB9/PSMB8/TERF2IP/HIST1H2AC/TUBB3/GSTP1/HSPA1B/CDKN1A/SOD1/HSPA5/FOS/HSPA6/PSMD6/ELOB/H3F3A/MAP1LC3B/CDKN2C/GABARAPL2/PSMD7/PRDX3/PTGES3/HSBP1/DYNLL1/SNCB/H2AFZ/RBX1/RHEB/CAMK2B/PSME1/JUN/MT1F/P4HB/HIST1H2BK/TUBB4B/UBC/DNAJB1,45
R-HSA-2262752,R-HSA-2262752,Cellular responses to stress,39/331,378/8183,5.07505203814817e-08,1.36591400569588e-06,1.09132697963186e-06,TUBB2B/TUBA1A/HIST1H4C/CA9/CYBA/HSPA1A/TUBB2A/HIST1H1C/PSMB9/PSMB8/TERF2IP/HIST1H2AC/TUBB3/GSTP1/HSPA1B/CDKN1A/SOD1/HSPA5/FOS/HSPA6/PSMD6/ELOB/H3F3A/CDKN2C/PSMD7/PRDX3/PTGES3/HSBP1/DYNLL1/H2AFZ/RBX1/CAMK2B/PSME1/JUN/P4HB/HIST1H2BK/TUBB4B/UBC/DNAJB1,39
R-HSA-389977,R-HSA-389977,Post-chaperonin tubulin folding pathway,8/331,16/8183,6.38718725112796e-08,1.67131399737848e-06,1.33533300718026e-06,TUBB2B/TUBA1A/TUBB2A/TBCD/TUBB3/TBCA/ARL2/TUBB4B,8
R-HSA-1236975,R-HSA-1236975,Antigen processing-Cross presentation,17/331,89/8183,7.35812946670945e-08,1.87333998855143e-06,1.49674610773748e-06,B2M/HLA-C/HLA-A/HLA-B/PDIA3/SEC61G/CALR/VAMP8/CYBA/PSMB9/PSMB8/PSMD6/HLA-E/PSMD7/CTSL/PSME1/UBC,17
R-HSA-1428517,R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,23/331,158/8183,7.80035794130021e-08,1.93366767913284e-06,1.54494624045143e-06,BSG/ATP5F1E/NDUFAF3/NDUFA13/NDUFA11/COX7C/UQCR11/NDUFB4/NDUFB5/COX4I1/ATP5PO/NDUFB1/COX6C/UQCR10/PDHB/NDUFA3/UQCRC1/MDH2/NDUFC2/ATP5ME/NDUFA6/UQCRFS1/NDUFS5,23
R-HSA-611105,R-HSA-611105,Respiratory electron transport,17/331,90/8183,8.74268850941818e-08,2.11169553227485e-06,1.68718550181754e-06,NDUFAF3/NDUFA13/NDUFA11/COX7C/UQCR11/NDUFB4/NDUFB5/COX4I1/NDUFB1/COX6C/UQCR10/NDUFA3/UQCRC1/NDUFC2/NDUFA6/UQCRFS1/NDUFS5,17
R-HSA-1236974,R-HSA-1236974,ER-Phagosome pathway,15/331,78/8183,3.98527424820512e-07,9.38532085452307e-06,7.49860812491227e-06,B2M/HLA-C/HLA-A/HLA-B/PDIA3/SEC61G/CALR/VAMP8/PSMB9/PSMB8/PSMD6/HLA-E/PSMD7/PSME1/UBC,15
R-HSA-1236977,R-HSA-1236977,Endosomal/Vacuolar pathway,6/331,11/8183,1.62918534376923e-06,3.74315266787956e-05,2.9906739943389e-05,B2M/HLA-C/HLA-A/HLA-B/HLA-E/CTSL,6
R-HSA-983170,R-HSA-983170,Antigen Presentation: Folding, assembly and peptide loading of class I MHC,8/331,25/8183,3.89640100233802e-06,8.73907081952956e-05,6.98227247286137e-05,B2M/HLA-C/HLA-A/HLA-B/PDIA3/CALR/HSPA5/HLA-E,8
R-HSA-3371497,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),10/331,46/8183,1.13751981600911e-05,0.000249196201553624,0.000199100775629502,TUBB2B/TUBA1A/HSPA1A/TUBB2A/TUBB3/HSPA1B/PTGES3/DYNLL1/TUBB4B/DNAJB1,10
R-HSA-8852276,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,12/331,69/8183,1.7335897117251e-05,0.000371145797373873,0.000296535082268766,TUBB2B/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/CDKN1A/PSMD6/PSMD7/PSME1/TUBB4B/UBC,12
R-HSA-6799198,R-HSA-6799198,Complex I biogenesis,10/331,49/8183,2.05819109444828e-05,0.00043084800243784,0.000344235469597783,NDUFAF3/NDUFA13/NDUFA11/NDUFB4/NDUFB5/NDUFB1/NDUFA3/NDUFC2/NDUFA6/NDUFS5,10
R-HSA-5626467,R-HSA-5626467,RHO GTPases activate IQGAPs,7/331,26/8183,5.62306454071235e-05,0.00115150582551109,0.000920020857347673,TUBB2B/TUBA1A/TUBB2A/TUBB3/CDC42/RAC1/TUBB4B,7
R-HSA-190840,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,5/331,12/8183,6.5800254730245e-05,0.00129132999908106,0.0010317364502659,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-190872,R-HSA-190872,Transport of connexons to the plasma membrane,5/331,12/8183,6.5800254730245e-05,0.00129132999908106,0.0010317364502659,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-3371568,R-HSA-3371568,Attenuation phase,5/331,14/8183,0.00015553360938835,0.00299005428660869,0.00238896951047627,HSPA1A/HSPA1B/PTGES3/HSBP1/DNAJB1,5
R-HSA-9609736,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,7/331,31/8183,0.000188779722507361,0.00355660997203869,0.00284163161247923,TUBB2B/TUBA1A/TUBB2A/NEFL/TUBB3/CAMK2B/TUBB4B,7
R-HSA-5663220,R-HSA-5663220,RHO GTPases Activate Formins,15/331,131/8183,0.00024884598856914,0.0045963317888653,0.00367234018218649,TUBB2B/RPS27/RHOA/TUBA1A/TUBB2A/PFN2/TUBB3/MAD1L1/CDC42/DAAM1/DYNLL1/RAC1/RHOB/PFN1/TUBB4B,15
R-HSA-195258,R-HSA-195258,RHO GTPase Effectors,25/331,291/8183,0.000290100605829471,0.00525528405175696,0.00419882455805814,TUBB2B/RPS27/RHOA/TUBA1A/HIST1H4C/BRK1/CYBA/TUBB2A/PFN2/HIST1H2AC/TUBB3/MYL6/MAD1L1/MYL12B/CDC42/H3F3A/DAAM1/DYNLL1/KTN1/RAC1/RHOB/H2AFZ/PFN1/HIST1H2BK/TUBB4B,25
R-HSA-3371571,R-HSA-3371571,HSF1-dependent transactivation,6/331,24/8183,0.000303465508579175,0.00539366998267137,0.00430939103543416,HSPA1A/HSPA1B/PTGES3/HSBP1/CAMK2B/DNAJB1,6
R-HSA-5358351,R-HSA-5358351,Signaling by Hedgehog,15/331,134/8183,0.000319280051618944,0.00556966312268602,0.0044500046180808,TUBB2B/TUBA1A/EVC2/TUBB2A/OS9/PSMB9/PSMB8/TUBB3/PSMD6/PSMD7/RBX1/PSME1/P4HB/TUBB4B/UBC,15
R-HSA-381183,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,4/331,10/8183,0.000454852986649657,0.00779039115316322,0.00622430402783742,HSP90B1/CALR/HSPA5/DDIT3,4
R-HSA-4086400,R-HSA-4086400,PCP/CE pathway,11/331,86/8183,0.000649022512207974,0.0109174858303556,0.00872276496670492,RHOA/PSMB9/PSMB8/PSMD6/DAAM1/PSMD7/RAC1/PFN1/AP2M1/PSME1/UBC,11
R-HSA-5625970,R-HSA-5625970,RHO GTPases activate KTN1,4/331,11/8183,0.000692086103611652,0.0114376335017926,0.0091383483671714,RHOA/CDC42/KTN1/RAC1,4
R-HSA-190861,R-HSA-190861,Gap junction assembly,5/331,19/8183,0.000764286424766586,0.0122026747818665,0.00974959489220534,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-389960,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,5/331,19/8183,0.000764286424766586,0.0122026747818665,0.00974959489220534,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-391251,R-HSA-391251,Protein folding,11/331,88/8183,0.000790162238819518,0.0123951622220266,0.00990338695803894,TUBB2B/TUBA1A/RGS7/TUBB2A/GNG2/TBCD/TUBB3/TBCA/ARL2/GNG5/TUBB4B,11
R-HSA-5610787,R-HSA-5610787,Hedgehog 'off' state,12/331,102/8183,0.000802659124780919,0.0123951622220266,0.00990338695803894,TUBB2B/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/PSMD6/PSMD7/RBX1/PSME1/TUBB4B/UBC,12
R-HSA-5625740,R-HSA-5625740,RHO GTPases activate PKNs,10/331,75/8183,0.000816638016539776,0.0124076292190398,0.00991334773898031,RHOA/HIST1H4C/HIST1H2AC/MYL6/MYL12B/H3F3A/RAC1/RHOB/H2AFZ/HIST1H2BK,10
R-HSA-114608,R-HSA-114608,Platelet degranulation ,12/331,103/8183,0.000876265867621181,0.0131022610682405,0.010468339103578,TIMP1/CD9/TAGLN2/LGALS3BP/CD63/PSAP/SOD1/HSPA5/MANF/HGF/CHID1/PFN1,12
R-HSA-190828,R-HSA-190828,Gap junction trafficking,6/331,29/8183,0.000902741713668321,0.0132872295980556,0.010616123770935,TUBB2B/TUBA1A/TUBB2A/TUBB3/AP2M1/TUBB4B,6
R-HSA-5625900,R-HSA-5625900,RHO GTPases activate CIT,5/331,20/8183,0.000985635264377754,0.0141332200660495,0.0112920464266683,RHOA/MYL6/MYL12B/RAC1/RHOB,5
R-HSA-381033,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,4/331,12/8183,0.00100522902805236,0.0141332200660495,0.0112920464266683,HSP90B1/CALR/HSPA5/DDIT3,4
R-HSA-381771,R-HSA-381771,Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),4/331,12/8183,0.00100522902805236,0.0141332200660495,0.0112920464266683,GRP/SPCS1/SEC11C/SEC11A,4
R-HSA-180585,R-HSA-180585,Vif-mediated degradation of APOBEC3G,8/331,52/8183,0.0010445833150066,0.014470551216709,0.0115615645546396,PSMB9/PSMB8/PSMD6/ELOB/PSMD7/RBX1/PSME1/UBC,8
R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,12/331,106/8183,0.00113166149860767,0.0154496395896873,0.0123438287033483,TIMP1/CD9/TAGLN2/LGALS3BP/CD63/PSAP/SOD1/HSPA5/MANF/HGF/CHID1/PFN1,12
R-HSA-162909,R-HSA-162909,Host Interactions of HIV factors,13/331,122/8183,0.00125830752445491,0.0169332241148075,0.0135291711275979,B2M/PSMB9/PSMB8/SLC25A6/ELMO1/PSMD6/ELOB/PSMD7/RAC1/RBX1/AP2M1/PSME1/UBC,13
R-HSA-157858,R-HSA-157858,Gap junction trafficking and regulation,6/331,31/8183,0.00130702755850986,0.017341126198821,0.0138550734519578,TUBB2B/TUBA1A/TUBB2A/TUBB3/AP2M1/TUBB4B,6
R-HSA-450408,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,8/331,54/8183,0.00134639104738595,0.0176152828699662,0.014074116942704,HSPA1A/PSMB9/PSMB8/HSPA1B/PSMD6/PSMD7/PSME1/UBC,8
R-HSA-400508,R-HSA-400508,Incretin synthesis, secretion, and inactivation,4/331,13/8183,0.00140604379561453,0.0181437432256012,0.014496341944692,GRP/SPCS1/SEC11C/SEC11A,4
R-HSA-5687128,R-HSA-5687128,MAPK6/MAPK4 signaling,10/331,81/8183,0.00149374585525837,0.0190149810223431,0.0151924365079621,PSMB9/PSMB8/PSMD6/CDC42/PSMD7/RAC1/PSME1/JUN/UBC/DNAJB1,10
R-HSA-438064,R-HSA-438064,Post NMDA receptor activation events,9/331,68/8183,0.00155817611550841,0.0194139273321276,0.015511183419903,TUBB2B/TUBA1A/TUBB2A/NEFL/TUBB3/RAC1/HRAS/CAMK2B/TUBB4B,9
R-HSA-9619483,R-HSA-9619483,Activation of AMPK downstream of NMDARs,5/331,22/8183,0.00156630411596783,0.0194139273321276,0.015511183419903,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-76002,R-HSA-76002,Platelet activation, signaling and aggregation,18/331,207/8183,0.00177256622608507,0.0215279832389569,0.0172002547947862,TIMP1/RHOA/CD9/TAGLN2/LGALS3BP/CD63/GNG2/PSAP/SOD1/HSPA5/MANF/HGF/CDC42/RAC1/RHOB/CHID1/PFN1/GNG5,18
R-HSA-195721,R-HSA-195721,Signaling by WNT,22/331,276/8183,0.00178257186055057,0.0215279832389569,0.0172002547947862,RHOA/SOX4/HIST1H4C/GNG2/PSMB9/PSMB8/HIST1H2AC/PSMD6/H3F3A/DAAM1/PSMD7/SNX3/RAC1/H2AFZ/HDAC1/RBX1/PFN1/AP2M1/GNG5/PSME1/HIST1H2BK/UBC,22
R-HSA-109582,R-HSA-109582,Hemostasis,32/331,461/8183,0.00184439835491917,0.0219926993713146,0.0175715499502626,TUBB2B/TIMP1/RHOA/EPCAM/CD9/BSG/TUBA1A/TAGLN2/LGALS3BP/CD63/TUBB2A/GNG2/PSAP/TUBB3/SOD1/HSPA5/CD74/MANF/HGF/CDC42/H3F3A/CD47/ANGPT2/RAC1/RHOB/HDAC1/CHID1/PFN1/HRAS/GNG5/MIF/TUBB4B,32
R-HSA-8849471,R-HSA-8849471,PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases,4/331,14/8183,0.001906247870105,0.0224460686704864,0.0179337793042773,RHOA/ELMO1/RAC1/HRAS,4
R-HSA-1234174,R-HSA-1234174,Cellular response to hypoxia,9/331,71/8183,0.00211778306185811,0.0246290326453129,0.0196779062927687,CA9/PSMB9/PSMB8/PSMD6/ELOB/PSMD7/RBX1/PSME1/UBC,9
R-HSA-389957,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,5/331,24/8183,0.00236556778976027,0.026528153070883,0.0211952502465989,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-397795,R-HSA-397795,G-protein beta:gamma signalling,5/331,24/8183,0.00236556778976027,0.026528153070883,0.0211952502465989,RHOA/GNG2/CDC42/AKT3/GNG5,5
R-HSA-400685,R-HSA-400685,Sema4D in semaphorin signaling,5/331,24/8183,0.00236556778976027,0.026528153070883,0.0211952502465989,RHOA/MYL6/MYL12B/RAC1/RHOB,5
R-HSA-3858494,R-HSA-3858494,Beta-catenin independent WNT signaling,13/331,131/8183,0.00240203015982823,0.026620146006567,0.0212687500220085,RHOA/GNG2/PSMB9/PSMB8/PSMD6/DAAM1/PSMD7/RAC1/PFN1/AP2M1/GNG5/PSME1/UBC,13
R-HSA-425397,R-HSA-425397,Transport of vitamins, nucleosides, and related molecules,6/331,35/8183,0.00251490906996486,0.0275470272547314,0.0220093021422873,APOD/LCN15/SLC25A6/LCN12/ARL2/SLC29A1,6
R-HSA-5358346,R-HSA-5358346,Hedgehog ligand biogenesis,8/331,61/8183,0.0029826635269065,0.0322950464637463,0.0258028363186709,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/P4HB/UBC,8
R-HSA-2559582,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),10/331,89/8183,0.00304139560034004,0.0325567574490945,0.0260119360555398,HIST1H4C/HIST1H2AC/CDKN1A/FOS/H3F3A/CDKN2C/H2AFZ/JUN/HIST1H2BK/UBC,10
R-HSA-442755,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,9/331,76/8183,0.00339584620341397,0.0358603635998018,0.0286514247109825,TUBB2B/TUBA1A/TUBB2A/NEFL/TUBB3/RAC1/HRAS/CAMK2B/TUBB4B,9
R-HSA-389958,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,5/331,26/8183,0.00342614938851609,0.0358603635998018,0.0286514247109825,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-1234176,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,8/331,63/8183,0.00365808507334688,0.0378672103197006,0.030254838952493,PSMB9/PSMB8/PSMD6/ELOB/PSMD7/RBX1/PSME1/UBC,8
R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,6/331,38/8183,0.0038636083426283,0.039207414059682,0.031325624150936,SOD1/CDC42/HNRNPF/MIF/GSTO1/P4HB,6
R-HSA-8939236,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,11/331,107/8183,0.0038707956555737,0.039207414059682,0.031325624150936,HIST1H4C/PSMB9/PSMB8/HIST1H2AC/PSMD6/H3F3A/PSMD7/H2AFZ/PSME1/HIST1H2BK/UBC,11
R-HSA-112314,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,14/331,155/8183,0.00397055900300037,0.0397900700087909,0.031791149912041,TUBB2B/TUBA1A/TUBB2A/GNG2/NEFL/TUBB3/RAC1/NPTN/GRIK2/AP2M1/HRAS/CAMK2B/GNG5/TUBB4B,14
R-HSA-5658442,R-HSA-5658442,Regulation of RAS by GAPs,8/331,65/8183,0.00444622649200362,0.0440878458470254,0.035224952263519,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/HRAS/PSME1/UBC,8
R-HSA-8854050,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,7/331,52/8183,0.0046403270072886,0.0455332087590194,0.0363797566909139,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-3299685,R-HSA-3299685,Detoxification of Reactive Oxygen Species,5/331,28/8183,0.0047912170897486,0.0461502062668148,0.0368727203942034,CYBA/GSTP1/SOD1/PRDX3/P4HB,5
R-HSA-977225,R-HSA-977225,Amyloid fiber formation,9/331,80/8183,0.00480118918699348,0.0461502062668148,0.0368727203942034,B2M/HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/NCSTN/NPPA/HIST1H2BK/UBC,9
R-HSA-437239,R-HSA-437239,Recycling pathway of L1,6/331,40/8183,0.00502030635010867,0.0477689755737613,0.0381660716674928,TUBB2B/TUBA1A/TUBB2A/TUBB3/AP2M1/TUBB4B,6
R-HSA-5362768,R-HSA-5362768,Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,7/331,53/8183,0.00516570170594462,0.0486609100699983,0.0388787023131622,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-157118,R-HSA-157118,Signaling by NOTCH,17/331,212/8183,0.00541604669182658,0.0505140196406004,0.0403592848843774,MDK/HIST1H4C/PSMB9/PSMB8/HIST1H2AC/DLK1/PSMD6/H3F3A/PSMD7/H2AFZ/NCSTN/HDAC1/RBX1/PSME1/JUN/HIST1H2BK/UBC,17
R-HSA-4641258,R-HSA-4641258,Degradation of DVL,7/331,54/8183,0.00573453520828315,0.0524459433611915,0.0419028377508682,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-9604323,R-HSA-9604323,Negative regulation of NOTCH4 signaling,7/331,54/8183,0.00573453520828315,0.0524459433611915,0.0419028377508682,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-392451,R-HSA-392451,G beta:gamma signalling through PI3Kgamma,4/331,19/8183,0.00629056142961544,0.0565746766557609,0.0452015798512337,RHOA/GNG2/AKT3/GNG5,4
R-HSA-5387390,R-HSA-5387390,Hh mutants abrogate ligand secretion,7/331,55/8183,0.00634896670926374,0.0565746766557609,0.0452015798512337,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-83936,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,3/331,10/8183,0.00636615257485207,0.0565746766557609,0.0452015798512337,SLC25A6/ARL2/SLC29A1,3
R-HSA-499943,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,5/331,30/8183,0.00650346085302297,0.057254767509791,0.0457449533685334,NME1/NME3/NME4/NME2/CTPS1,5
R-HSA-5610780,R-HSA-5610780,Degradation of GLI1 by the proteasome,7/331,56/8183,0.00701114303310998,0.0600408794289964,0.0479709786475946,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-5610783,R-HSA-5610783,Degradation of GLI2 by the proteasome,7/331,56/8183,0.00701114303310998,0.0600408794289964,0.0479709786475946,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-5610785,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,7/331,56/8183,0.00701114303310998,0.0600408794289964,0.0479709786475946,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-6811436,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,6/331,43/8183,0.00720545985103668,0.0611490376547438,0.048856365988537,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/TUBB4B,6
R-HSA-5627117,R-HSA-5627117,RHO GTPases Activate ROCKs,4/331,20/8183,0.00761679297092487,0.0640626694518859,0.0511842760734143,RHOA/MYL6/MYL12B/RHOB,4
R-HSA-427389,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,7/331,57/8183,0.00772321357298555,0.0643828954491362,0.051440127663574,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HDAC1/CHD4/HIST1H2BK,7
R-HSA-6807070,R-HSA-6807070,PTEN Regulation,12/331,134/8183,0.00791633679797219,0.0654139409095597,0.0522639040678681,PSMB9/PSMB8/EGR1/PSMD6/AKT3/PSMD7/HDAC1/RHEB/CHD4/PSME1/JUN/UBC,12
R-HSA-9006931,R-HSA-9006931,Signaling by Nuclear Receptors,17/331,221/8183,0.0081291025390685,0.0665879529721959,0.0532019067774278,TFF3/FABP5/HIST1H4C/GNG2/HIST1H2AC/FOS/POLR2H/H3F3A/AKT3/PTGES3/PDHB/H2AFZ/HDAC1/HRAS/GNG5/JUN/HIST1H2BK,17
R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,8/331,72/8183,0.00826478502057282,0.0671157542187897,0.0536236051697783,TIMP1/HSP90B1/FSCN1/CEBPD/CDKN1A/FOS/HGF/JUNB,8
R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,5/331,32/8183,0.00860425241039179,0.0686881844965175,0.0548799328584311,SOD1/CDC42/HNRNPF/MIF/GSTO1,5
R-HSA-8955332,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,5/331,32/8183,0.00860425241039179,0.0686881844965175,0.0548799328584311,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-69275,R-HSA-69275,G2/M Transition,15/331,187/8183,0.00870649914185345,0.0689203545514785,0.0550654302204796,TUBB2B/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/CDKN1A/PSMD6/PSMD7/DYNLL1/RBX1/AKAP9/PSME1/TUBB4B/UBC,15
R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,6/331,45/8183,0.00899933953128752,0.070644815320607,0.0564432260076366,SOD1/CDC42/HNRNPF/MIF/GSTO1/P4HB,6
R-HSA-416572,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,4/331,21/8183,0.00911456272940475,0.0709580007528866,0.0566934523838573,RHOA/MYL6/MYL12B/RHOB,4
R-HSA-5678895,R-HSA-5678895,Defective CFTR causes cystic fibrosis,7/331,59/8183,0.00930561737950495,0.0718515702581448,0.0574073893558761,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-453274,R-HSA-453274,Mitotic G2-G2/M phases,15/331,189/8183,0.00955893043547439,0.0732074184570477,0.0584906740382044,TUBB2B/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/CDKN1A/PSMD6/PSMD7/DYNLL1/RBX1/AKAP9/PSME1/TUBB4B/UBC,15
R-HSA-8939211,R-HSA-8939211,ESR-mediated signaling,15/331,190/8183,0.0100092387381605,0.0760379265431227,0.0607521706093784,TFF3/HIST1H4C/GNG2/HIST1H2AC/FOS/POLR2H/H3F3A/AKT3/PTGES3/H2AFZ/HDAC1/HRAS/GNG5/JUN/HIST1H2BK,15
R-HSA-187577,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,7/331,60/8183,0.0101802168579813,0.0767181142417474,0.0612956215027929,PSMB9/PSMB8/CDKN1A/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-5683057,R-HSA-5683057,MAPK family signaling cascades,18/331,246/8183,0.0107607299056972,0.0781243695131152,0.0624191800222118,PSMB9/NEFL/PSMB8/RET/HGF/PSMD6/CDC42/PSMD7/RAC1/RBX1/HRAS/CAMK2B/PSME1/JUN/DUSP1/UBC/DNAJB1/DUSP2,18
R-HSA-422085,R-HSA-422085,Synthesis, secretion, and deacylation of Ghrelin,3/331,12/8183,0.0109901603260722,0.0781243695131152,0.0624191800222118,SPCS1/SEC11C/SEC11A,3
R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),9/331,91/8183,0.0110301829524454,0.0781243695131152,0.0624191800222118,TIMP1/HSP90B1/CHGB/PDIA6/IGFBP2/IGFBP5/KTN1/NUCB1/P4HB,9
R-HSA-6807878,R-HSA-6807878,COPI-mediated anterograde transport,9/331,91/8183,0.0110301829524454,0.0781243695131152,0.0624191800222118,TUBB2B/TUBA1A/TUBB2A/TUBB3/FOLR1/DYNLL1/TMED10/ARF4/TUBB4B,9
R-HSA-110328,R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,6/331,47/8183,0.011091912170057,0.0781243695131152,0.0624191800222118,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/NTHL1/HIST1H2BK,6
R-HSA-110329,R-HSA-110329,Cleavage of the damaged pyrimidine ,6/331,47/8183,0.011091912170057,0.0781243695131152,0.0624191800222118,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/NTHL1/HIST1H2BK,6
R-HSA-73928,R-HSA-73928,Depyrimidination,6/331,47/8183,0.011091912170057,0.0781243695131152,0.0624191800222118,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/NTHL1/HIST1H2BK,6
R-HSA-2132295,R-HSA-2132295,MHC class II antigen presentation,10/331,107/8183,0.0111082060811072,0.0781243695131152,0.0624191800222118,TUBB2B/TUBA1A/TUBB2A/TUBB3/CD74/RAB7A/CTSL/DYNLL1/AP2M1/TUBB4B,10
R-HSA-2980736,R-HSA-2980736,Peptide hormone metabolism,7/331,61/8183,0.0111132330305281,0.0781243695131152,0.0624191800222118,CPB1/GRP/CPE/SPCS1/MME/SEC11C/SEC11A,7
R-HSA-449147,R-HSA-449147,Signaling by Interleukins,23/331,342/8183,0.0113142930229689,0.0785051907728636,0.0627234455275422,TIMP1/HSP90B1/FSCN1/PSMB9/PSMB8/CEBPD/CDKN1A/SOD1/FOS/HGF/PSMD6/CDC42/IL17RB/PSMD7/RBX1/HNRNPF/MIF/GSTO1/PSME1/JUN/P4HB/JUNB/UBC,23
R-HSA-5632684,R-HSA-5632684,Hedgehog 'on' state,8/331,76/8183,0.0113340827442776,0.0785051907728636,0.0627234455275422,EVC2/PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,8
R-HSA-211733,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,6/331,48/8183,0.0122577310045074,0.0842830847171235,0.0673398207316385,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-164952,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,4/331,23/8183,0.0126563725607156,0.0863934996535807,0.0690259830733157,B2M/ELMO1/RAC1/AP2M1,4
R-HSA-195253,R-HSA-195253,Degradation of beta-catenin by the destruction complex,8/331,78/8183,0.0131511300720062,0.0879389495226985,0.0702607541722309,PSMB9/PSMB8/PSMD6/PSMD7/HDAC1/RBX1/PSME1/UBC,8
R-HSA-73884,R-HSA-73884,Base Excision Repair,8/331,78/8183,0.0131511300720062,0.0879389495226985,0.0702607541722309,HIST1H4C/TERF2IP/HIST1H2AC/BPHL/H2AFZ/NTHL1/APEX1/HIST1H2BK,8
R-HSA-2559586,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,7/331,63/8183,0.0131628363935249,0.0879389495226985,0.0702607541722309,HIST1H4C/HIST1H1C/TERF2IP/HIST1H2AC/CDKN1A/H2AFZ/HIST1H2BK,7
R-HSA-180534,R-HSA-180534,Vpu mediated degradation of CD4,6/331,49/8183,0.0135071189911248,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-350562,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),6/331,49/8183,0.0135071189911248,0.0881691503848532,0.0704446782044586,OAZ1/PSMB9/PSMB8/PSMD6/PSMD7/PSME1,6
R-HSA-73929,R-HSA-73929,Base-Excision Repair, AP Site Formation,6/331,49/8183,0.0135071189911248,0.0881691503848532,0.0704446782044586,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/NTHL1/HIST1H2BK,6
R-HSA-9018519,R-HSA-9018519,Estrogen-dependent gene expression,11/331,127/8183,0.0136310248579953,0.0881691503848532,0.0704446782044586,TFF3/HIST1H4C/HIST1H2AC/FOS/POLR2H/H3F3A/PTGES3/H2AFZ/HDAC1/JUN/HIST1H2BK,11
R-HSA-3000480,R-HSA-3000480,Scavenging by Class A Receptors,3/331,13/8183,0.0138653952852095,0.0881691503848532,0.0704446782044586,HSP90B1/FTH1/CALR,3
R-HSA-351202,R-HSA-351202,Metabolism of polyamines,8/331,79/8183,0.0141356288098049,0.0881691503848532,0.0704446782044586,OAZ1/PSMB9/PSMB8/PSMD6/PSMD7/ADI1/PSME1/SRM,8
R-HSA-1445148,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,7/331,64/8183,0.0142835115491829,0.0881691503848532,0.0704446782044586,TUBB2B/TUBA1A/RAB13/TUBB2A/TUBB3/RAC1/TUBB4B,7
R-HSA-69563,R-HSA-69563,p53-Dependent G1 DNA Damage Response,7/331,64/8183,0.0142835115491829,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/CDKN1A/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-69580,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,7/331,64/8183,0.0142835115491829,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/CDKN1A/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-2424491,R-HSA-2424491,DAP12 signaling,4/331,24/8183,0.0147145335149067,0.0881691503848532,0.0704446782044586,B2M/HLA-E/RAC1/HRAS,4
R-HSA-5627123,R-HSA-5627123,RHO GTPases activate PAKs,4/331,24/8183,0.0147145335149067,0.0881691503848532,0.0704446782044586,MYL6/MYL12B/CDC42/RAC1,4
R-HSA-349425,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-5620924,R-HSA-5620924,Intraflagellar transport,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/TUBB4B,6
R-HSA-69601,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-69610,R-HSA-69610,p53-Independent DNA Damage Response,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-69613,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-75815,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,6/331,50/8183,0.0148428899094567,0.0881691503848532,0.0704446782044586,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-2467813,R-HSA-2467813,Separation of Sister Chromatids,14/331,181/8183,0.014882054045851,0.0881691503848532,0.0704446782044586,TUBB2B/RPS27/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/MAD1L1/PSMD6/PSMD7/DYNLL1/PSME1/TUBB4B/UBC,14
R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,8/331,80/8183,0.015172788767895,0.0893297938709821,0.0713719997963484,TIMP1/HSP90B1/CHGB/PDIA6/IGFBP5/KTN1/NUCB1/P4HB,8
R-HSA-169911,R-HSA-169911,Regulation of Apoptosis,6/331,51/8183,0.0162677706190945,0.0951816144297329,0.0760474402919421,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-69615,R-HSA-69615,G1/S DNA Damage Checkpoints,7/331,66/8183,0.0167265629293522,0.0966651673585876,0.0772327574716618,PSMB9/PSMB8/CDKN1A/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-8948751,R-HSA-8948751,Regulation of PTEN stability and activity,7/331,66/8183,0.0167265629293522,0.0966651673585876,0.0772327574716618,PSMB9/PSMB8/PSMD6/AKT3/PSMD7/PSME1/UBC,7
R-HSA-390466,R-HSA-390466,Chaperonin-mediated protein folding,8/331,82/8183,0.0174110105732605,0.0994010421818873,0.0794186447201357,TUBB2B/TUBA1A/RGS7/TUBB2A/GNG2/TUBB3/GNG5/TUBB4B,8
R-HSA-9013694,R-HSA-9013694,Signaling by NOTCH4,8/331,82/8183,0.0174110105732605,0.0994010421818873,0.0794186447201357,PSMB9/PSMB8/PSMD6/PSMD7/NCSTN/RBX1/PSME1/UBC,8
R-HSA-171306,R-HSA-171306,Packaging Of Telomere Ends,5/331,38/8183,0.0176169687160091,0.0999709911474735,0.0798740179578094,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-909733,R-HSA-909733,Interferon alpha/beta signaling,6/331,52/8183,0.0177843936988952,0.100316759666822,0.0801502773067135,HLA-C/HLA-A/HLA-B/PSMB8/EGR1/HLA-E,6
R-HSA-69202,R-HSA-69202,Cyclin E associated events during G1/S transition ,8/331,83/8183,0.0186149741648971,0.104376819424601,0.0833941511773271,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/PSMD7/PSME1/UBC,8
R-HSA-174113,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,6/331,53/8183,0.0193952905490592,0.106464023012103,0.0850617683022168,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-4641257,R-HSA-4641257,Degradation of AXIN,6/331,53/8183,0.0193952905490592,0.106464023012103,0.0850617683022168,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-901042,R-HSA-901042,Calnexin/calreticulin cycle,4/331,26/8183,0.0194354085440219,0.106464023012103,0.0850617683022168,PDIA3/CALR/OS9/UBC,4
R-HSA-8939902,R-HSA-8939902,Regulation of RUNX2 expression and activity,7/331,68/8183,0.0194513255817316,0.106464023012103,0.0850617683022168,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-373760,R-HSA-373760,L1CAM interactions,9/331,100/8183,0.0195523099586984,0.106464023012103,0.0850617683022168,TUBB2B/CD24/TUBA1A/TUBB2A/TUBB3/ALCAM/RAC1/AP2M1/TUBB4B,9
R-HSA-163210,R-HSA-163210,Formation of ATP by chemiosmotic coupling,3/331,15/8183,0.0207793792800056,0.112495260240031,0.089880557684235,ATP5F1E/ATP5PO/ATP5ME,3
R-HSA-68949,R-HSA-68949,Orc1 removal from chromatin,7/331,69/8183,0.020923955414276,0.11263066285856,0.0899887405786907,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-69656,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,8/331,85/8183,0.0211996617982194,0.113466371670015,0.0906564484792277,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/PSMD7/PSME1/UBC,8
R-HSA-112315,R-HSA-112315,Transmission across Chemical Synapses,15/331,208/8183,0.0213558617497112,0.11365662015948,0.0908084516862534,TUBB2B/TUBA1A/TUBB2A/GNG2/NEFL/TUBB3/CACNA2D1/RAC1/NPTN/GRIK2/AP2M1/HRAS/CAMK2B/GNG5/TUBB4B,15
R-HSA-5619084,R-HSA-5619084,ABC transporter disorders,7/331,70/8183,0.0224724318107275,0.118533188696403,0.0947046931701063,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-450531,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,8/331,86/8183,0.0225831176228865,0.118533188696403,0.0947046931701063,HSPA1A/PSMB9/PSMB8/HSPA1B/PSMD6/PSMD7/PSME1/UBC,8
R-HSA-194315,R-HSA-194315,Signaling by Rho GTPases,25/331,405/8183,0.0226496538910324,0.118533188696403,0.0947046931701063,TUBB2B/RPS27/RHOA/TUBA1A/HIST1H4C/BRK1/CYBA/TUBB2A/PFN2/HIST1H2AC/TUBB3/MYL6/MAD1L1/MYL12B/CDC42/H3F3A/DAAM1/DYNLL1/KTN1/RAC1/RHOB/H2AFZ/PFN1/HIST1H2BK/TUBB4B,25
R-HSA-69541,R-HSA-69541,Stabilization of p53,6/331,55/8183,0.0229094872022552,0.118575477717167,0.0947384809115815,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-8941858,R-HSA-8941858,Regulation of RUNX3 expression and activity,6/331,55/8183,0.0229094872022552,0.118575477717167,0.0947384809115815,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-68882,R-HSA-68882,Mitotic Anaphase,14/331,192/8183,0.023597897960327,0.121471146877749,0.0970520393536599,TUBB2B/RPS27/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/MAD1L1/PSMD6/PSMD7/DYNLL1/PSME1/TUBB4B/UBC,14
R-HSA-2682334,R-HSA-2682334,EPH-Ephrin signaling,8/331,87/8183,0.024029080199998,0.121695664238699,0.0972314224278355,RHOA/MYL6/MYL12B/CDC42/RAC1/NCSTN/AP2M1/HRAS,8
R-HSA-3371556,R-HSA-3371556,Cellular response to heat stress,8/331,87/8183,0.024029080199998,0.121695664238699,0.0972314224278355,HSPA1A/HSPA1B/HSPA5/HSPA6/PTGES3/HSBP1/CAMK2B/DNAJB1,8
R-HSA-5250913,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,8/331,87/8183,0.024029080199998,0.121695664238699,0.0972314224278355,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/CHD4/HIST1H2BK,8
R-HSA-201681,R-HSA-201681,TCF dependent signaling in response to WNT,14/331,193/8183,0.0245471208978459,0.122468773239744,0.0978491148356432,SOX4/HIST1H4C/PSMB9/PSMB8/HIST1H2AC/PSMD6/H3F3A/PSMD7/H2AFZ/HDAC1/RBX1/PSME1/HIST1H2BK/UBC,14
R-HSA-2555396,R-HSA-2555396,Mitotic Metaphase and Anaphase,14/331,193/8183,0.0245471208978459,0.122468773239744,0.0978491148356432,TUBB2B/RPS27/TUBA1A/TUBB2A/PSMB9/PSMB8/TUBB3/MAD1L1/PSMD6/PSMD7/DYNLL1/PSME1/TUBB4B/UBC,14
R-HSA-2559580,R-HSA-2559580,Oxidative Stress Induced Senescence,9/331,104/8183,0.0245717602359996,0.122468773239744,0.0978491148356432,HIST1H4C/HIST1H2AC/FOS/H3F3A/CDKN2C/H2AFZ/JUN/HIST1H2BK/UBC,9
R-HSA-8964616,R-HSA-8964616,G beta:gamma signalling through CDC42,3/331,16/8183,0.024824452401465,0.122627527169594,0.0979759547728908,GNG2/CDC42/GNG5,3
R-HSA-114604,R-HSA-114604,GPVI-mediated activation cascade,4/331,28/8183,0.0249941456651402,0.122627527169594,0.0979759547728908,RHOA/CDC42/RAC1/RHOB,4
R-HSA-2172127,R-HSA-2172127,DAP12 interactions,4/331,28/8183,0.0249941456651402,0.122627527169594,0.0979759547728908,B2M/HLA-E/RAC1/HRAS,4
R-HSA-110330,R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,5/331,42/8183,0.0262072170760352,0.126601017875001,0.101150662398732,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-110331,R-HSA-110331,Cleavage of the damaged purine,5/331,42/8183,0.0262072170760352,0.126601017875001,0.101150662398732,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-73927,R-HSA-73927,Depurination,5/331,42/8183,0.0262072170760352,0.126601017875001,0.101150662398732,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-1257604,R-HSA-1257604,PIP3 activates AKT signaling,16/331,233/8183,0.0267548758405828,0.127637936793578,0.101979131531353,PSMB9/PSMB8/EGR1/CDKN1A/HGF/PSMD6/AKT3/PSMD7/RAC1/HDAC1/RHEB/CHD4/PSME1/NR4A1/JUN/UBC,16
R-HSA-5676590,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,6/331,57/8183,0.0268283561413252,0.127637936793578,0.101979131531353,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-68827,R-HSA-68827,CDT1 association with the CDC6:ORC:origin complex,6/331,57/8183,0.0268283561413252,0.127637936793578,0.101979131531353,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-2454202,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,10/331,124/8183,0.0283828526152057,0.134355010871979,0.107345885320667,PSMB9/PSMB8/FOS/PSMD6/PSMD7/RAC1/HRAS/PSME1/JUN/UBC,10
R-HSA-5607761,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,6/331,58/8183,0.0289446289386465,0.136329202301025,0.108923208900696,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-8878166,R-HSA-8878166,Transcriptional regulation by RUNX2,9/331,108/8183,0.0304468593617975,0.141360217377219,0.112942848837537,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/PSMD7/RBX1/PSME1/UBC,9
R-HSA-4420097,R-HSA-4420097,VEGFA-VEGFR2 Pathway,8/331,91/8183,0.0304629767808657,0.141360217377219,0.112942848837537,RHOA/BRK1/CYBA/ELMO1/CDC42/AKT3/RAC1/HRAS,8
R-HSA-73854,R-HSA-73854,RNA Polymerase I Promoter Clearance,8/331,91/8183,0.0304629767808657,0.141360217377219,0.112942848837537,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/CHD4/HIST1H2BK,8
R-HSA-73728,R-HSA-73728,RNA Polymerase I Promoter Opening,5/331,44/8183,0.031353711404273,0.144374509201669,0.115351183460938,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-2871796,R-HSA-2871796,FCERI mediated MAPK activation,4/331,30/8183,0.0314190810895352,0.144374509201669,0.115351183460938,FOS/RAC1/HRAS/JUN,4
R-HSA-73864,R-HSA-73864,RNA Polymerase I Transcription,8/331,92/8183,0.0322398448840246,0.147426863498792,0.117789928932435,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/CHD4/HIST1H2BK,8
R-HSA-8964038,R-HSA-8964038,LDL clearance,3/331,18/8183,0.0340886469321832,0.153911116894111,0.122970665526081,NPC2/LSR/AP2M1,3
R-HSA-1236978,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),5/331,45/8183,0.0341480078883963,0.153911116894111,0.122970665526081,PSMB9/PSMB8/PSMD6/PSMD7/PSME1,5
R-HSA-5334118,R-HSA-5334118,DNA methylation,5/331,45/8183,0.0341480078883963,0.153911116894111,0.122970665526081,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-4608870,R-HSA-4608870,Asymmetric localization of PCP proteins,6/331,61/8183,0.0359420591521888,0.161225808196961,0.128814898715865,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-1168372,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),7/331,78/8183,0.0377787913987293,0.168661713258782,0.134755978299284,PSMB9/PSMB8/PSMD6/PSMD7/HRAS/PSME1/UBC,7
R-HSA-5689603,R-HSA-5689603,UCH proteinases,8/331,95/8183,0.0379917871085728,0.168812563472998,0.134876503389422,UCHL1/PSMB9/PSMB8/HIST1H2AC/PSMD6/PSMD7/PSME1/UBC,8
R-HSA-983169,R-HSA-983169,Class I MHC mediated antigen processing & presentation,21/331,344/8183,0.0386936459608881,0.17112401171435,0.136723285703163,B2M/HLA-C/HLA-A/HLA-B/PDIA3/SEC61G/CALR/VAMP8/CYBA/PSMB9/PSMB8/HSPA5/PSMD6/ELOB/HLA-E/PSMD7/CTSL/RNF7/RBX1/PSME1/UBC,21
R-HSA-442982,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,3/331,19/8183,0.0393007879639146,0.172996926457979,0.138219692052135,NEFL/HRAS/CAMK2B,3
R-HSA-2559583,R-HSA-2559583,Cellular Senescence,12/331,168/8183,0.0395503352057507,0.173285654715428,0.138450377831636,HIST1H4C/HIST1H1C/TERF2IP/HIST1H2AC/CDKN1A/FOS/H3F3A/CDKN2C/H2AFZ/JUN/HIST1H2BK/UBC,12
R-HSA-5625886,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,5/331,47/8183,0.0401873171917987,0.1752613555309,0.140028907369084,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-174084,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,6/331,63/8183,0.0411624741287344,0.177867204721412,0.142110907783897,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-373755,R-HSA-373755,Semaphorin interactions,6/331,63/8183,0.0411624741287344,0.177867204721412,0.142110907783897,RHOA/MYL6/MYL12B/RAC1/DPYSL3/RHOB,6
R-HSA-194138,R-HSA-194138,Signaling by VEGF,8/331,97/8183,0.0421870459079624,0.181462087878085,0.144983118597419,RHOA/BRK1/CYBA/ELMO1/CDC42/AKT3/RAC1/HRAS,8
R-HSA-5673001,R-HSA-5673001,RAF/MAP kinase cascade,14/331,208/8183,0.0424124714750753,0.181602491497822,0.145095297151573,PSMB9/NEFL/PSMB8/RET/HGF/PSMD6/PSMD7/RBX1/HRAS/CAMK2B/PSME1/DUSP1/UBC/DUSP2,14
R-HSA-1169091,R-HSA-1169091,Activation of NF-kappaB in B cells,6/331,64/8183,0.0439430564645501,0.18730479271315,0.149651275885465,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-427359,R-HSA-427359,SIRT1 negatively regulates rRNA expression,5/331,49/8183,0.0468358326405467,0.19609736759115,0.156676296600372,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-8848021,R-HSA-8848021,Signaling by PTK6,5/331,49/8183,0.0468358326405467,0.19609736759115,0.156676296600372,RHOA/ELMO1/RAC1/HRAS/UBC,5
R-HSA-9006927,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,5/331,49/8183,0.0468358326405467,0.19609736759115,0.156676296600372,RHOA/ELMO1/RAC1/HRAS/UBC,5
R-HSA-174154,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,6/331,65/8183,0.0468385432144467,0.19609736759115,0.156676296600372,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-9006925,R-HSA-9006925,Intracellular signaling by second messengers,17/331,271/8183,0.0478896985167689,0.19961104426016,0.159483625707917,PSMB9/PSMB8/EGR1/CDKN1A/HGF/PSMD6/AKT3/PSMD7/RAC1/HDAC1/RHEB/CAMK2B/CHD4/PSME1/NR4A1/JUN/UBC,17
R-HSA-68867,R-HSA-68867,Assembly of the pre-replicative complex,6/331,66/8183,0.0498497412429562,0.206668378340943,0.165122237695579,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-5684996,R-HSA-5684996,MAPK1/MAPK3 signaling,14/331,213/8183,0.0500216457130944,0.206668378340943,0.165122237695579,PSMB9/NEFL/PSMB8/RET/HGF/PSMD6/PSMD7/RBX1/HRAS/CAMK2B/PSME1/DUSP1/UBC/DUSP2,14
R-HSA-983189,R-HSA-983189,Kinesins,5/331,50/8183,0.0503906040551123,0.207283620174305,0.165613798664239,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-5205685,R-HSA-5205685,Pink/Parkin Mediated Mitophagy,3/331,21/8183,0.0508550009427328,0.207382731117118,0.165692985527701,TOMM7/MAP1LC3B/UBC,3
R-HSA-9609523,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,3/331,21/8183,0.0508550009427328,0.207382731117118,0.165692985527701,CYB5A/SEC61G/SERP1,3
R-HSA-532668,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,4/331,35/8183,0.0513602604588023,0.208540367897378,0.166617904845933,PDIA3/CALR/OS9/UBC,4
R-HSA-196071,R-HSA-196071,Metabolism of steroid hormones,3/331,22/8183,0.0571807452706815,0.230189154038384,0.183914677771198,TSPO/AKR1B1/HSD17B11,3
R-HSA-2979096,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,3/331,22/8183,0.0571807452706815,0.230189154038384,0.183914677771198,MDK/NCSTN/UBC,3
R-HSA-111367,R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,2/331,10/8183,0.0592242208910922,0.234408470921886,0.187285793618447,SNRPF/SNRPE,2
R-HSA-2022377,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,2/331,10/8183,0.0592242208910922,0.234408470921886,0.187285793618447,CPB1/MME,2
R-HSA-450341,R-HSA-450341,Activation of the AP-1 family of transcription factors,2/331,10/8183,0.0592242208910922,0.234408470921886,0.187285793618447,FOS/JUN,2
R-HSA-8875656,R-HSA-8875656,MET receptor recycling,2/331,10/8183,0.0592242208910922,0.234408470921886,0.187285793618447,HGF/ARF6,2
R-HSA-201722,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,6/331,69/8183,0.0595834553552237,0.234843577174145,0.187633431310218,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HDAC1/HIST1H2BK,6
R-HSA-162906,R-HSA-162906,HIV Infection,14/331,219/8183,0.0603450858741219,0.236854462055928,0.189240071929812,B2M/PSMB9/PSMB8/SLC25A6/ELMO1/POLR2H/PSMD6/ELOB/PSMD7/RAC1/RBX1/AP2M1/PSME1/UBC,14
R-HSA-427413,R-HSA-427413,NoRC negatively regulates rRNA expression,7/331,87/8183,0.0617541434227658,0.240588845233056,0.192223739347006,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/HIST1H2BK,7
R-HSA-8878171,R-HSA-8878171,Transcriptional regulation by RUNX1,13/331,200/8183,0.0618073254208064,0.240588845233056,0.192223739347006,HIST1H4C/PSMB9/PSMB8/HIST1H2AC/PSMD6/H3F3A/PSMD7/CTSL/H2AFZ/HDAC1/PSME1/HIST1H2BK/UBC,13
R-HSA-174178,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,6/331,70/8183,0.0630626138125202,0.242469315148547,0.193726182066389,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-174184,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,6/331,70/8183,0.0630626138125202,0.242469315148547,0.193726182066389,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-69017,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,6/331,70/8183,0.0630626138125202,0.242469315148547,0.193726182066389,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-913531,R-HSA-913531,Interferon Signaling,11/331,162/8183,0.063823996602909,0.244399206503822,0.195268111129996,B2M/HLA-C/HLA-A/HLA-B/EIF4A2/PSMB8/EGR1/EIF4A1/HLA-E/CAMK2B/UBC,11
R-HSA-380320,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,7/331,88/8183,0.0648838620150464,0.246454024266829,0.196909852889466,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/AKAP9/TUBB4B,7
R-HSA-69052,R-HSA-69052,Switching of origins to a post-replicative state,7/331,88/8183,0.0648838620150464,0.246454024266829,0.196909852889466,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-212300,R-HSA-212300,PRC2 methylates histones and DNA,5/331,54/8183,0.0661515646390021,0.249178837048047,0.199086901876582,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-2299718,R-HSA-2299718,Condensation of Prophase Chromosomes,5/331,54/8183,0.0661515646390021,0.249178837048047,0.199086901876582,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-179419,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,6/331,71/8183,0.066659306726229,0.249178837048047,0.199086901876582,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-877300,R-HSA-877300,Interferon gamma signaling,6/331,71/8183,0.066659306726229,0.249178837048047,0.199086901876582,B2M/HLA-C/HLA-A/HLA-B/HLA-E/CAMK2B,6
R-HSA-382556,R-HSA-382556,ABC-family proteins mediated transport,7/331,89/8183,0.0681081525284528,0.252590077487412,0.201812387309754,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-6811434,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,7/331,89/8183,0.0681081525284528,0.252590077487412,0.201812387309754,TUBB2B/TUBA1A/TUBB2A/TUBB3/TMED10/ARF4/TUBB4B,7
R-HSA-983231,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,9/331,126/8183,0.0689180352412245,0.254591330185229,0.203411332084522,TUBB2B/TUBA1A/TUBB2A/TUBB3/CDC42/H3F3A/RAC1/HDAC1/TUBB4B,9
R-HSA-5250924,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,6/331,72/8183,0.0703734615661456,0.255418298060062,0.204072056221862,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HIST1H2BK,6
R-HSA-73772,R-HSA-73772,RNA Polymerase I Promoter Escape,6/331,72/8183,0.0703734615661456,0.255418298060062,0.204072056221862,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HIST1H2BK,6
R-HSA-77588,R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,2/331,11/8183,0.0704976194220977,0.255418298060062,0.204072056221862,SNRPF/SNRPE,2
R-HSA-8851805,R-HSA-8851805,MET activates RAS signaling,2/331,11/8183,0.0704976194220977,0.255418298060062,0.204072056221862,HGF/HRAS,2
R-HSA-8875555,R-HSA-8875555,MET activates RAP1 and RAC1,2/331,11/8183,0.0704976194220977,0.255418298060062,0.204072056221862,HGF/RAC1,2
R-HSA-5663202,R-HSA-5663202,Diseases of signal transduction,20/331,348/8183,0.0710313125031721,0.255834043866805,0.204404225460684,RBP1/OS9/PSMB9/PSMB8/CDKN1A/POLR2H/HGF/PSMD6/AKT3/PSMD7/RAC1/NCSTN/HDAC1/RBX1/HRAS/CAMK2B/AKAP9/PSME1/NR4A1/UBC,20
R-HSA-5675221,R-HSA-5675221,Negative regulation of MAPK pathway,4/331,39/8183,0.0712840476844007,0.255834043866805,0.204404225460684,HRAS/DUSP1/UBC/DUSP2,4
R-HSA-5250941,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,7/331,90/8183,0.0714271268969955,0.255834043866805,0.204404225460684,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/HIST1H2BK,7
R-HSA-176409,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,6/331,73/8183,0.0742048633478029,0.26377728782502,0.210750654592568,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-8936459,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,6/331,73/8183,0.0742048633478029,0.26377728782502,0.210750654592568,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HDAC1/HIST1H2BK,6
R-HSA-202733,R-HSA-202733,Cell surface interactions at the vascular wall,7/331,91/8183,0.0748408060733398,0.265037741808594,0.211757721972449,EPCAM/BSG/CD74/CD47/ANGPT2/HRAS/MIF,7
R-HSA-453279,R-HSA-453279,Mitotic G1-G1/S phases,10/331,148/8183,0.0768878424983855,0.271267219601045,0.216734900005305,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/CDKN2C/PSMD7/HDAC1/PSME1/UBC,10
R-HSA-176814,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,6/331,74/8183,0.0781531566486021,0.271932596892311,0.21726651779864,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-1912408,R-HSA-1912408,Pre-NOTCH Transcription and Translation,6/331,74/8183,0.0781531566486021,0.271932596892311,0.21726651779864,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/JUN/HIST1H2BK,6
R-HSA-6806834,R-HSA-6806834,Signaling by MET,6/331,74/8183,0.0781531566486021,0.271932596892311,0.21726651779864,SPINT2/HGF/RAC1/HRAS/ARF6/UBC,6
R-HSA-5674400,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,3/331,25/8183,0.0782311398702934,0.271932596892311,0.21726651779864,CDKN1A/AKT3/NR4A1,3
R-HSA-69206,R-HSA-69206,G1/S Transition,9/331,130/8183,0.0803589474396238,0.27830194297105,0.222355446669238,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/PSMD7/HDAC1/PSME1/UBC,9
R-HSA-8878159,R-HSA-8878159,Transcriptional regulation by RUNX3,7/331,93/8183,0.0819519108874504,0.278632327909287,0.22261941496831,PSMB9/PSMB8/CDKN1A/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-2871837,R-HSA-2871837,FCERI mediated NF-kB activation,6/331,75/8183,0.0822178479004998,0.278632327909287,0.22261941496831,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-156581,R-HSA-156581,Methylation,2/331,12/8183,0.0823991112413028,0.278632327909287,0.22261941496831,TRMT112/GSTO1,2
R-HSA-3371511,R-HSA-3371511,HSF1 activation,2/331,12/8183,0.0823991112413028,0.278632327909287,0.22261941496831,PTGES3/HSBP1,2
R-HSA-418885,R-HSA-418885,DCC mediated attractive signaling,2/331,12/8183,0.0823991112413028,0.278632327909287,0.22261941496831,CDC42/RAC1,2
R-HSA-5660526,R-HSA-5660526,Response to metal ions,2/331,12/8183,0.0823991112413028,0.278632327909287,0.22261941496831,SNCB/MT1F,2
R-HSA-3928662,R-HSA-3928662,EPHB-mediated forward signaling,4/331,41/8183,0.0825248614508399,0.278632327909287,0.22261941496831,RHOA/CDC42/RAC1/HRAS,4
R-HSA-8943724,R-HSA-8943724,Regulation of PTEN gene transcription,5/331,58/8183,0.0843562398605213,0.283798492673611,0.226747035715311,EGR1/HDAC1/RHEB/CHD4/JUN,5
R-HSA-9020702,R-HSA-9020702,Interleukin-1 signaling,7/331,94/8183,0.0856489287843226,0.285929115556586,0.228449343639467,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-3928663,R-HSA-3928663,EPHA-mediated growth cone collapse,3/331,26/8183,0.0859001483041548,0.285929115556586,0.228449343639467,RHOA/MYL6/MYL12B,3
R-HSA-8949613,R-HSA-8949613,Cristae formation,3/331,26/8183,0.0859001483041548,0.285929115556586,0.228449343639467,ATP5F1E/ATP5PO/ATP5ME,3
R-HSA-8854214,R-HSA-8854214,TBC/RABGAPs,4/331,42/8183,0.0884530345429244,0.293389994857165,0.234410376939181,MAP1LC3B/GABARAPL2/RAB7A/ARF6,4
R-HSA-5617472,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,7/331,96/8183,0.0933242144941002,0.306806034483161,0.245129416309599,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/JUN/HIST1H2BK,7
R-HSA-5619507,R-HSA-5619507,Activation of HOX genes during differentiation,7/331,96/8183,0.0933242144941002,0.306806034483161,0.245129416309599,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/JUN/HIST1H2BK,7
R-HSA-156590,R-HSA-156590,Glutathione conjugation,3/331,27/8183,0.0938741652157351,0.306806034483161,0.245129416309599,GSTP1/GGCT/GSTO1,3
R-HSA-442742,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,3/331,27/8183,0.0938741652157351,0.306806034483161,0.245129416309599,NEFL/HRAS/CAMK2B,3
R-HSA-1358803,R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,2/331,13/8183,0.0948597868696835,0.306806034483161,0.245129416309599,AKT3/UBC,2
R-HSA-2024101,R-HSA-2024101,CS/DS degradation,2/331,13/8183,0.0948597868696835,0.306806034483161,0.245129416309599,HEXB/IDS,2
R-HSA-3229121,R-HSA-3229121,Glycogen storage diseases,2/331,13/8183,0.0948597868696835,0.306806034483161,0.245129416309599,GYG1/UBC,2
R-HSA-176408,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,6/331,78/8183,0.0951033567612347,0.306806034483161,0.245129416309599,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-68886,R-HSA-68886,M Phase,20/331,364/8183,0.100382906384884,0.322732757046281,0.257854420927579,TUBB2B/RPS27/TUBA1A/HIST1H4C/TUBB2A/PSMB9/PSMB8/HIST1H2AC/TUBB3/MAD1L1/PSMD6/H3F3A/PSMD7/DYNLL1/H2AFZ/AKAP9/PSME1/HIST1H2BK/TUBB4B/UBC,20
R-HSA-5205647,R-HSA-5205647,Mitophagy,3/331,28/8183,0.102139767561806,0.326154783197361,0.260588523841897,TOMM7/MAP1LC3B/UBC,3
R-HSA-75067,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,3/331,28/8183,0.102139767561806,0.326154783197361,0.260588523841897,SNRPF/SNRPE/PAPOLA,3
R-HSA-1221632,R-HSA-1221632,Meiotic synapsis,5/331,62/8183,0.104924430350165,0.333914910100864,0.266788647583102,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-198323,R-HSA-198323,AKT phosphorylates targets in the cytosol,2/331,14/8183,0.107815254523985,0.338539899205313,0.270483884156664,CDKN1A/AKT3,2
R-HSA-210993,R-HSA-210993,Tie2 Signaling,2/331,14/8183,0.107815254523985,0.338539899205313,0.270483884156664,ANGPT2/HRAS,2
R-HSA-3322077,R-HSA-3322077,Glycogen synthesis,2/331,14/8183,0.107815254523985,0.338539899205313,0.270483884156664,GYG1/UBC,2
R-HSA-8964315,R-HSA-8964315,G beta:gamma signalling through BTK,2/331,14/8183,0.107815254523985,0.338539899205313,0.270483884156664,GNG2/GNG5,2
R-HSA-2500257,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,8/331,119/8183,0.108693190948075,0.340162743764407,0.271780491442117,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/DYNLL1/TUBB4B,8
R-HSA-446203,R-HSA-446203,Asparagine N-linked glycosylation,16/331,283/8183,0.109958371229098,0.340730524484606,0.272234132312541,TUBB2B/PDIA3/CALR/TUBA1A/TUBB2A/OS9/TUBB3/FOLR1/RPN1/TUSC3/DYNLL1/DDOST/TMED10/ARF4/TUBB4B/UBC,16
R-HSA-198933,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,5/331,63/8183,0.110421150714082,0.340730524484606,0.272234132312541,B2M/HLA-C/HLA-A/HLA-B/HLA-E,5
R-HSA-451326,R-HSA-451326,Activation of kainate receptors upon glutamate binding,3/331,29/8183,0.110683164004553,0.340730524484606,0.272234132312541,GNG2/GRIK2/GNG5,3
R-HSA-5663084,R-HSA-5663084,Diseases of carbohydrate metabolism,3/331,29/8183,0.110683164004553,0.340730524484606,0.272234132312541,GYG1/IDS/UBC,3
R-HSA-8964043,R-HSA-8964043,Plasma lipoprotein clearance,3/331,29/8183,0.110683164004553,0.340730524484606,0.272234132312541,NPC2/LSR/AP2M1,3
R-HSA-5668541,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,6/331,82/8183,0.113860643872948,0.347922291086667,0.277980152114166,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-69002,R-HSA-69002,DNA Replication Pre-Initiation,6/331,82/8183,0.113860643872948,0.347922291086667,0.277980152114166,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-983705,R-HSA-983705,Signaling by the B Cell Receptor (BCR),7/331,101/8183,0.11412737573862,0.347922291086667,0.277980152114166,PSMB9/PSMB8/PSMD6/PSMD7/HRAS/PSME1/UBC,7
R-HSA-8856688,R-HSA-8856688,Golgi-to-ER retrograde transport,8/331,121/8183,0.116614379685835,0.354357244077602,0.283121499067477,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/TMED10/ARF4/TUBB4B,8
R-HSA-199977,R-HSA-199977,ER to Golgi Anterograde Transport,9/331,141/8183,0.117409150020136,0.355625142504722,0.284134514348951,TUBB2B/TUBA1A/TUBB2A/TUBB3/FOLR1/DYNLL1/TMED10/ARF4/TUBB4B,9
R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/331,30/8183,0.119490284328444,0.358470852985332,0.286408157206965,HSP90B1/FTH1/CALR,3
R-HSA-389356,R-HSA-389356,CD28 co-stimulation,3/331,30/8183,0.119490284328444,0.358470852985332,0.286408157206965,CDC42/AKT3/RAC1,3
R-HSA-6804758,R-HSA-6804758,Regulation of TP53 Activity through Acetylation,3/331,30/8183,0.119490284328444,0.358470852985332,0.286408157206965,AKT3/HDAC1/CHD4,3
R-HSA-1227986,R-HSA-1227986,Signaling by ERBB2,4/331,47/8183,0.120990643135829,0.36017500506197,0.287769726918436,RHOA/AKT3/HRAS/UBC,4
R-HSA-392851,R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,2/331,15/8183,0.121205389176905,0.36017500506197,0.287769726918436,GNG2/GNG5,2
R-HSA-430039,R-HSA-430039,mRNA decay by 5' to 3' exoribonuclease,2/331,15/8183,0.121205389176905,0.36017500506197,0.287769726918436,LSM3/LSM5,2
R-HSA-912446,R-HSA-912446,Meiotic recombination,5/331,65/8183,0.121822916206593,0.360871657442172,0.288326332630633,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-174143,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,6/331,84/8183,0.123891825439941,0.364303328496913,0.291068141552456,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-453276,R-HSA-453276,Regulation of mitotic cell cycle,6/331,84/8183,0.123891825439941,0.364303328496913,0.291068141552456,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-109581,R-HSA-109581,Apoptosis,10/331,163/8183,0.124141580092897,0.364303328496913,0.291068141552456,HIST1H1C/PSMB9/PSMB8/PSMD6/AKT3/PSMD7/DSP/DYNLL1/PSME1/UBC,10
R-HSA-73856,R-HSA-73856,RNA Polymerase II Transcription Termination,5/331,66/8183,0.127722356777383,0.373647391566133,0.298533785864102,THOC7/SNRPF/SRSF9/SNRPE/PAPOLA,5
R-HSA-2122948,R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,3/331,31/8183,0.128546860768464,0.3737380951972,0.298606255521285,DLK1/NCSTN/UBC,3
R-HSA-2173796,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,3/331,31/8183,0.128546860768464,0.3737380951972,0.298606255521285,HDAC1/JUNB/UBC,3
R-HSA-1474165,R-HSA-1474165,Reproduction,7/331,105/8183,0.132378560158544,0.381480140067406,0.304791932225048,CD9/HIST1H4C/TERF2IP/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,7
R-HSA-156580,R-HSA-156580,Phase II - Conjugation of compounds,5/331,67/8183,0.133750183159575,0.381480140067406,0.304791932225048,GSTP1/GGCT/PODXL2/TRMT112/GSTO1,5
R-HSA-3371453,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,5/331,67/8183,0.133750183159575,0.381480140067406,0.304791932225048,HSPA1A/HSPA1B/HSPA5/HSPA6/DNAJB1,5
R-HSA-9009391,R-HSA-9009391,Non-genomic estrogen signaling,5/331,67/8183,0.133750183159575,0.381480140067406,0.304791932225048,GNG2/FOS/AKT3/HRAS/GNG5,5
R-HSA-202424,R-HSA-202424,Downstream TCR signaling,6/331,86/8183,0.134341034300624,0.381480140067406,0.304791932225048,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-5578749,R-HSA-5578749,Transcriptional regulation by small RNAs,6/331,86/8183,0.134341034300624,0.381480140067406,0.304791932225048,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HIST1H2BK,6
R-HSA-205043,R-HSA-205043,NRIF signals cell death from the nucleus,2/331,16/8183,0.134974094430539,0.381480140067406,0.304791932225048,NCSTN/UBC,2
R-HSA-2173791,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),2/331,16/8183,0.134974094430539,0.381480140067406,0.304791932225048,RHOA/UBC,2
R-HSA-5357801,R-HSA-5357801,Programmed Cell Death,10/331,166/8183,0.135166787133418,0.381480140067406,0.304791932225048,HIST1H1C/PSMB9/PSMB8/PSMD6/AKT3/PSMD7/DSP/DYNLL1/PSME1/UBC,10
R-HSA-174824,R-HSA-174824,Plasma lipoprotein assembly, remodeling, and clearance,4/331,49/8183,0.13525941272029,0.381480140067406,0.304791932225048,NPC2/LSR/AP2M1/P4HB,4
R-HSA-1980145,R-HSA-1980145,Signaling by NOTCH2,3/331,32/8183,0.137838501813048,0.387593637934003,0.309676445550131,MDK/NCSTN/UBC,3
R-HSA-381119,R-HSA-381119,Unfolded Protein Response (UPR),6/331,87/8183,0.139717841032318,0.391064822393867,0.312449824574383,HSP90B1/CALR/PDIA6/SERP1/HSPA5/DDIT3,6
R-HSA-157579,R-HSA-157579,Telomere Maintenance,5/331,68/8183,0.139903232639844,0.391064822393867,0.312449824574383,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-212165,R-HSA-212165,Epigenetic regulation of gene expression,8/331,128/8183,0.146676658800154,0.407023391710475,0.325200273855168,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HDAC1/CHD4/HIST1H2BK,8
R-HSA-445355,R-HSA-445355,Smooth Muscle Contraction,3/331,33/8183,0.14735075901068,0.407023391710475,0.325200273855168,MYL6/MYL12B/TPM3,3
R-HSA-1296041,R-HSA-1296041,Activation of G protein gated Potassium channels,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,GNG2/GNG5,2
R-HSA-1296059,R-HSA-1296059,G protein gated Potassium channels,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,GNG2/GNG5,2
R-HSA-392170,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,GNG2/GNG5,2
R-HSA-418217,R-HSA-418217,G beta:gamma signalling through PLC beta,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,GNG2/GNG5,2
R-HSA-5576893,R-HSA-5576893,Phase 2 - plateau phase,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,CACNA2D1/AKAP9,2
R-HSA-997272,R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,2/331,17/8183,0.149069076581862,0.407023391710475,0.325200273855168,GNG2/GNG5,2
R-HSA-1632852,R-HSA-1632852,Macroautophagy,6/331,89/8183,0.15076593264841,0.410466787730642,0.327951450695507,TOMM7/MAP1LC3B/GABARAPL2/DYNLL1/RHEB/UBC,6
R-HSA-15869,R-HSA-15869,Metabolism of nucleotides,6/331,90/8183,0.156432990202083,0.422234603926538,0.33735360577436,NME1/NME3/NME4/NME2/APRT/CTPS1,6
R-HSA-1912422,R-HSA-1912422,Pre-NOTCH Expression and Processing,6/331,90/8183,0.156432990202083,0.422234603926538,0.33735360577436,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/JUN/HIST1H2BK,6
R-HSA-193704,R-HSA-193704,p75 NTR receptor-mediated signalling,6/331,90/8183,0.156432990202083,0.422234603926538,0.33735360577436,RHOA/BEX3/RAC1/NCSTN/HDAC1/UBC,6
R-HSA-72165,R-HSA-72165,mRNA Splicing - Minor Pathway,4/331,52/8183,0.157858909076774,0.424865978143775,0.339455999969605,SNRPF/POLR2H/SNRPE/TXNL4A,4
R-HSA-170834,R-HSA-170834,Signaling by TGF-beta Receptor Complex,5/331,71/8183,0.159080239429918,0.426933292145251,0.341107725873119,RHOA/HDAC1/PPP1R15A/JUNB/UBC,5
R-HSA-1236382,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,HRAS/UBC,2
R-HSA-164938,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,B2M/AP2M1,2
R-HSA-418592,R-HSA-418592,ADP signalling through P2Y purinoceptor 1,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,GNG2/GNG5,2
R-HSA-428930,R-HSA-428930,Thromboxane signalling through TP receptor,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,GNG2/GNG5,2
R-HSA-438066,R-HSA-438066,Unblocking of NMDA receptors, glutamate binding and activation,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,NEFL/CAMK2B,2
R-HSA-500657,R-HSA-500657,Presynaptic function of Kainate receptors,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,GNG2/GNG5,2
R-HSA-5637815,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,2/331,18/8183,0.163441630288071,0.430061496456322,0.343607073378333,HRAS/UBC,2
R-HSA-8866654,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,4/331,53/8183,0.165685726911999,0.434751963094995,0.347354624665238,HLA-A/PRKDC/HIST1H2BK/UBC,4
R-HSA-2142753,R-HSA-2142753,Arachidonic acid metabolism,3/331,35/8183,0.166979399165818,0.435719096992245,0.348127337523137,PON3/PON2/PTGES3,3
R-HSA-5663213,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,3/331,35/8183,0.166979399165818,0.435719096992245,0.348127337523137,BRK1/CDC42/RAC1,3
R-HSA-1980143,R-HSA-1980143,Signaling by NOTCH1,5/331,73/8183,0.17242774270204,0.448693186810281,0.358493271392727,DLK1/NCSTN/HDAC1/RBX1/UBC,5
R-HSA-6804757,R-HSA-6804757,Regulation of TP53 Degradation,3/331,36/8183,0.177067113548476,0.458234123523803,0.366116212224292,SGK1/AKT3/UBC,3
R-HSA-6806003,R-HSA-6806003,Regulation of TP53 Expression and Degradation,3/331,36/8183,0.177067113548476,0.458234123523803,0.366116212224292,SGK1/AKT3/UBC,3
R-HSA-5668599,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,2/331,19/8183,0.178046435267384,0.459506142525687,0.367132519729429,CYBA/RAC1,2
R-HSA-1500620,R-HSA-1500620,Meiosis,6/331,94/8183,0.180001737634182,0.463283160796173,0.370150251390394,HIST1H4C/TERF2IP/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,6
R-HSA-446652,R-HSA-446652,Interleukin-1 family signaling,7/331,115/8183,0.183740236202754,0.471616628073553,0.376808458009376,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-1474228,R-HSA-1474228,Degradation of the extracellular matrix,6/331,95/8183,0.18610703425348,0.474031615827449,0.378737965489581,TIMP1/BSG/ELN/CAPN2/CTSL/NCSTN,6
R-HSA-5607764,R-HSA-5607764,CLEC7A (Dectin-1) signaling,6/331,95/8183,0.18610703425348,0.474031615827449,0.378737965489581,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-3214815,R-HSA-3214815,HDACs deacetylate histones,5/331,75/8183,0.186190762055367,0.474031615827449,0.378737965489581,HIST1H4C/HIST1H2AC/HDAC1/CHD4/HIST1H2BK,5
R-HSA-3769402,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,3/331,37/8183,0.18731819909887,0.474338020298751,0.378982774068172,SOX4/HDAC1/UBC,3
R-HSA-6814122,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,3/331,37/8183,0.18731819909887,0.474338020298751,0.378982774068172,RGS7/GNG2/GNG5,3
R-HSA-429914,R-HSA-429914,Deadenylation-dependent mRNA decay,4/331,56/8183,0.189954923158234,0.478442613944,0.382262229265796,EIF4A2/EIF4A1/LSM3/LSM5,4
R-HSA-9614085,R-HSA-9614085,FOXO-mediated transcription,4/331,56/8183,0.189954923158234,0.478442613944,0.382262229265796,CDKN1A/AKT3/HDAC1/DDIT3,4
R-HSA-1296065,R-HSA-1296065,Inwardly rectifying K+ channels,2/331,20/8183,0.192841363497319,0.480572921731414,0.383964285437435,GNG2/GNG5,2
R-HSA-420029,R-HSA-420029,Tight junction interactions,2/331,20/8183,0.192841363497319,0.480572921731414,0.383964285437435,CLDN18/CLDN7,2
R-HSA-8862803,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,2/331,20/8183,0.192841363497319,0.480572921731414,0.383964285437435,CAPN2/JUN,2
R-HSA-8863678,R-HSA-8863678,Neurodegenerative Diseases,2/331,20/8183,0.192841363497319,0.480572921731414,0.383964285437435,CAPN2/JUN,2
R-HSA-69242,R-HSA-69242,S Phase,9/331,159/8183,0.194651324911448,0.483144329012641,0.386018767732751,PSMB9/PSMB8/CDKN1A/PSMD6/AKT3/PSMD7/RBX1/PSME1/UBC,9
R-HSA-69239,R-HSA-69239,Synthesis of DNA,7/331,117/8183,0.194898986225906,0.483144329012641,0.386018767732751,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-977443,R-HSA-977443,GABA receptor activation,3/331,38/8183,0.197718712980601,0.488847841542588,0.390575714273048,GNG2/NPTN/GNG5,3
R-HSA-2029482,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,4/331,57/8183,0.198285153068288,0.488964958613422,0.390669287527765,BRK1/ELMO1/CDC42/RAC1,4
R-HSA-112316,R-HSA-112316,Neuronal System,16/331,314/8183,0.202638094884629,0.494146470663672,0.394809170325763,TUBB2B/TUBA1A/TUBB2A/GNG2/NEFL/TUBB3/CACNA2D1/RAC1/NPTN/GRIK2/AP2M1/HRAS/CAMK2B/GNG5/SLITRK6/TUBB4B,16
R-HSA-2644602,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,4/331,58/8183,0.206724331824419,0.494146470663672,0.394809170325763,NCSTN/HDAC1/RBX1/UBC,4
R-HSA-2644603,R-HSA-2644603,Signaling by NOTCH1 in Cancer,4/331,58/8183,0.206724331824419,0.494146470663672,0.394809170325763,NCSTN/HDAC1/RBX1/UBC,4
R-HSA-2644606,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,4/331,58/8183,0.206724331824419,0.494146470663672,0.394809170325763,NCSTN/HDAC1/RBX1/UBC,4
R-HSA-2894858,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,4/331,58/8183,0.206724331824419,0.494146470663672,0.394809170325763,NCSTN/HDAC1/RBX1/UBC,4
R-HSA-2894862,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,4/331,58/8183,0.206724331824419,0.494146470663672,0.394809170325763,NCSTN/HDAC1/RBX1/UBC,4
R-HSA-112409,R-HSA-112409,RAF-independent MAPK1/3 activation,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,DUSP1/DUSP2,2
R-HSA-202040,R-HSA-202040,G-protein activation,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,GNG2/GNG5,2
R-HSA-5223345,R-HSA-5223345,Miscellaneous transport and binding events,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,TUSC3/AZGP1,2
R-HSA-6807004,R-HSA-6807004,Negative regulation of MET activity,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,HGF/UBC,2
R-HSA-901032,R-HSA-901032,ER Quality Control Compartment (ERQC),2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,OS9/UBC,2
R-HSA-9617324,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,NEFL/CAMK2B,2
R-HSA-9634638,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,2/331,21/8183,0.207787296397801,0.494146470663672,0.394809170325763,FOS/AKT3,2
R-HSA-1236394,R-HSA-1236394,Signaling by ERBB4,3/331,39/8183,0.208254935088617,0.494146470663672,0.394809170325763,NCSTN/HRAS/UBC,3
R-HSA-73933,R-HSA-73933,Resolution of Abasic Sites (AP sites),3/331,39/8183,0.208254935088617,0.494146470663672,0.394809170325763,BPHL/NTHL1/APEX1,3
R-HSA-1643713,R-HSA-1643713,Signaling by EGFR in Cancer,2/331,22/8183,0.222847951510514,0.523498180356368,0.418260363118565,HRAS/UBC,2
R-HSA-420092,R-HSA-420092,Glucagon-type ligand receptors,2/331,22/8183,0.222847951510514,0.523498180356368,0.418260363118565,GNG2/GNG5,2
R-HSA-9006115,R-HSA-9006115,Signaling by NTRK2 (TRKB),2/331,22/8183,0.222847951510514,0.523498180356368,0.418260363118565,RAC1/HRAS,2
R-HSA-9620244,R-HSA-9620244,Long-term potentiation,2/331,22/8183,0.222847951510514,0.523498180356368,0.418260363118565,NEFL/CAMK2B,2
R-HSA-2219528,R-HSA-2219528,PI3K/AKT Signaling in Cancer,5/331,81/8183,0.229657351458917,0.536816935668238,0.42890167505061,CDKN1A/HGF/AKT3/RAC1/NR4A1,5
R-HSA-5628897,R-HSA-5628897,TP53 Regulates Metabolic Genes,5/331,81/8183,0.229657351458917,0.536816935668238,0.42890167505061,COX7C/COX4I1/AKT3/COX6C/RHEB,5
R-HSA-606279,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,4/331,61/8183,0.232627608429045,0.539741889507784,0.431238631129809,HIST1H4C/HIST1H2AC/H2AFZ/HIST1H2BK,4
R-HSA-6796648,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,4/331,61/8183,0.232627608429045,0.539741889507784,0.431238631129809,FOS/POLR2H/ELOB/JUN,4
R-HSA-774815,R-HSA-774815,Nucleosome assembly,4/331,61/8183,0.232627608429045,0.539741889507784,0.431238631129809,HIST1H4C/HIST1H2AC/H2AFZ/HIST1H2BK,4
R-HSA-5621481,R-HSA-5621481,C-type lectin receptors (CLRs),7/331,124/8183,0.235924186106743,0.544707312040568,0.435205864464193,PSMB9/PSMB8/PSMD6/PSMD7/HRAS/PSME1/UBC,7
R-HSA-69306,R-HSA-69306,DNA Replication,7/331,124/8183,0.235924186106743,0.544707312040568,0.435205864464193,PSMB9/PSMB8/PSMD6/PSMD7/RBX1/PSME1/UBC,7
R-HSA-2173795,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,2/331,23/8183,0.237989718208927,0.546795889153192,0.436874578997131,HDAC1/UBC,2
R-HSA-392518,R-HSA-392518,Signal amplification,2/331,23/8183,0.237989718208927,0.546795889153192,0.436874578997131,GNG2/GNG5,2
R-HSA-3899300,R-HSA-3899300,SUMOylation of transcription cofactors,3/331,42/8183,0.240544597296606,0.549983035566511,0.439421019588843,PARK7/SUMO2/DDX17,3
R-HSA-6782315,R-HSA-6782315,tRNA modification in the nucleus and cytosol,3/331,42/8183,0.240544597296606,0.549983035566511,0.439421019588843,TRIT1/TRMT112/EPRS,3
R-HSA-202403,R-HSA-202403,TCR signaling,6/331,104/8183,0.244343869866433,0.557317010688088,0.445280660008921,PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,6
R-HSA-373080,R-HSA-373080,Class B/2 (Secretin family receptors),4/331,63/8183,0.250317000324354,0.565158708245701,0.45154595641488,RAMP1/GNG2/GNG5/CALCB,4
R-HSA-5654738,R-HSA-5654738,Signaling by FGFR2,4/331,63/8183,0.250317000324354,0.565158708245701,0.45154595641488,POLR2H/HNRNPF/HRAS/UBC,4
R-HSA-948021,R-HSA-948021,Transport to the Golgi and subsequent modification,9/331,170/8183,0.250337080894321,0.565158708245701,0.45154595641488,TUBB2B/TUBA1A/TUBB2A/TUBB3/FOLR1/DYNLL1/TMED10/ARF4/TUBB4B,9
R-HSA-2173793,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,3/331,43/8183,0.251491883070416,0.565158708245701,0.45154595641488,HDAC1/JUNB/UBC,3
R-HSA-5696395,R-HSA-5696395,Formation of Incision Complex in GG-NER,3/331,43/8183,0.251491883070416,0.565158708245701,0.45154595641488,SUMO2/RBX1/UBC,3
R-HSA-379716,R-HSA-379716,Cytosolic tRNA aminoacylation,2/331,24/8183,0.25318150199542,0.565158708245701,0.45154595641488,EEF1E1/EPRS,2
R-HSA-399719,R-HSA-399719,Trafficking of AMPA receptors,2/331,24/8183,0.25318150199542,0.565158708245701,0.45154595641488,AP2M1/CAMK2B,2
R-HSA-399721,R-HSA-399721,Glutamate binding, activation of AMPA receptors and synaptic plasticity,2/331,24/8183,0.25318150199542,0.565158708245701,0.45154595641488,AP2M1/CAMK2B,2
R-HSA-9013507,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,2/331,24/8183,0.25318150199542,0.565158708245701,0.45154595641488,NCSTN/UBC,2
R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,11/331,216/8183,0.258255959016874,0.575123199512755,0.459507305454933,TIMP1/PPIB/BSG/MFAP2/ELN/CAPN2/CD47/CTSL/NCSTN/P4HA1/P4HB,11
R-HSA-69231,R-HSA-69231,Cyclin D associated events in G1,3/331,44/8183,0.262510545646059,0.581846903526089,0.464879356376303,CDKN1A/CDKN2C/UBC,3
R-HSA-69236,R-HSA-69236,G1 Phase,3/331,44/8183,0.262510545646059,0.581846903526089,0.464879356376303,CDKN1A/CDKN2C/UBC,3
R-HSA-2565942,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,5/331,86/8183,0.267887059167251,0.58797137557902,0.469772637768465,TUBA1A/DYNLL1/AKAP9/TUBB4B/UBC,5
R-HSA-3214858,R-HSA-3214858,RMTs methylate histone arginines,4/331,65/8183,0.268280587624552,0.58797137557902,0.469772637768465,HIST1H4C/HIST1H2AC/H2AFZ/COPRS,4
R-HSA-2173788,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,2/331,25/8183,0.268394576962822,0.58797137557902,0.469772637768465,PPP1R15A/UBC,2
R-HSA-400042,R-HSA-400042,Adrenaline,noradrenaline inhibits insulin secretion,2/331,25/8183,0.268394576962822,0.58797137557902,0.469772637768465,GNG2/GNG5,2
R-HSA-429947,R-HSA-429947,Deadenylation of mRNA,2/331,25/8183,0.268394576962822,0.58797137557902,0.469772637768465,EIF4A2/EIF4A1,2
R-HSA-416476,R-HSA-416476,G alpha (q) signalling events,7/331,131/8183,0.27948757062952,0.609438174844926,0.486924008284861,TAC3/GRP/GNG2/GNRH2/RGS2/HRAS/GNG5,7
R-HSA-73887,R-HSA-73887,Death Receptor Signalling,7/331,131/8183,0.27948757062952,0.609438174844926,0.486924008284861,RHOA/BEX3/CLIP3/RAC1/NCSTN/HDAC1/UBC,7
R-HSA-110373,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,2/331,26/8183,0.283602446017711,0.611335249768156,0.488439717939693,BPHL/APEX1,2
R-HSA-456926,R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),2/331,26/8183,0.283602446017711,0.611335249768156,0.488439717939693,GNG2/GNG5,2
R-HSA-6803529,R-HSA-6803529,FGFR2 alternative splicing,2/331,26/8183,0.283602446017711,0.611335249768156,0.488439717939693,POLR2H/HNRNPF,2
R-HSA-8863795,R-HSA-8863795,Downregulation of ERBB2 signaling,2/331,26/8183,0.283602446017711,0.611335249768156,0.488439717939693,AKT3/UBC,2
R-HSA-8982491,R-HSA-8982491,Glycogen metabolism,2/331,26/8183,0.283602446017711,0.611335249768156,0.488439717939693,GYG1/UBC,2
R-HSA-177929,R-HSA-177929,Signaling by EGFR,3/331,46/8183,0.28471487050919,0.611907472074811,0.488896907513118,CDC42/HRAS/UBC,3
R-HSA-211859,R-HSA-211859,Biological oxidations,7/331,132/8183,0.285876155333161,0.611907472074811,0.488896907513118,GSTP1/GGCT/BPHL/PODXL2/PTGES3/TRMT112/GSTO1,7
R-HSA-1474290,R-HSA-1474290,Collagen formation,4/331,67/8183,0.286466236926743,0.611907472074811,0.488896907513118,PPIB/CTSL/P4HA1/P4HB,4
R-HSA-416482,R-HSA-416482,G alpha (12/13) signalling events,4/331,67/8183,0.286466236926743,0.611907472074811,0.488896907513118,RHOA/GNG2/RHOB/GNG5,4
R-HSA-168898,R-HSA-168898,Toll-like Receptor Cascades,7/331,133/8183,0.292299616885473,0.622955292095283,0.497723805842136,S100A1/HSP90B1/FOS/CTSL/CNPY3/JUN/UBC,7
R-HSA-448424,R-HSA-448424,Interleukin-17 signaling,4/331,68/8183,0.295626424694674,0.624925938617103,0.499298297140718,FOS/IL17RB/JUN/UBC,4
R-HSA-2122947,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,3/331,47/8183,0.295877886011919,0.624925938617103,0.499298297140718,HDAC1/RBX1/UBC,3
R-HSA-421270,R-HSA-421270,Cell-cell junction organization,3/331,47/8183,0.295877886011919,0.624925938617103,0.499298297140718,CLDN18/CDH18/CLDN7,3
R-HSA-73762,R-HSA-73762,RNA Polymerase I Transcription Initiation,3/331,47/8183,0.295877886011919,0.624925938617103,0.499298297140718,POLR2H/HDAC1/CHD4,3
R-HSA-69481,R-HSA-69481,G2/M Checkpoints,8/331,156/8183,0.296584448293019,0.625016891033611,0.499370965570491,HIST1H4C/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/HIST1H2BK/UBC,8
R-HSA-5218920,R-HSA-5218920,VEGFR2 mediated vascular permeability,2/331,27/8183,0.298780708481869,0.626769491332344,0.500771244052549,AKT3/RAC1,2
R-HSA-70263,R-HSA-70263,Gluconeogenesis,2/331,27/8183,0.298780708481869,0.626769491332344,0.500771244052549,PGAM2/MDH2,2
R-HSA-166520,R-HSA-166520,Signaling by NTRKs,5/331,90/8183,0.299412177388062,0.626769491332344,0.500771244052549,RHOA/RAC1/AP2M1/KIDINS220/HRAS,5
R-HSA-380259,R-HSA-380259,Loss of Nlp from mitotic centrosomes,4/331,69/8183,0.30482323758418,0.634217584119313,0.506722061286523,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-380284,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,4/331,69/8183,0.30482323758418,0.634217584119313,0.506722061286523,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-5689880,R-HSA-5689880,Ub-specific processing proteases,9/331,180/8183,0.304989984719797,0.634217584119313,0.506722061286523,PSMB9/PSMB8/HIST1H2AC/PSMD6/PSMD7/SNX3/PSME1/HIST1H2BK/UBC,9
R-HSA-1650814,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,3/331,48/8183,0.3070670009937,0.634338897421555,0.506818987212439,PPIB/P4HA1/P4HB,3
R-HSA-3928665,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,3/331,48/8183,0.3070670009937,0.634338897421555,0.506818987212439,RAC1/NCSTN/AP2M1,3
R-HSA-211000,R-HSA-211000,Gene Silencing by RNA,6/331,113/8183,0.307068510853746,0.634338897421555,0.506818987212439,HIST1H4C/HIST1H2AC/POLR2H/H3F3A/H2AFZ/HIST1H2BK,6
R-HSA-163359,R-HSA-163359,Glucagon signaling in metabolic regulation,2/331,28/8183,0.313906934706489,0.643121015608606,0.513835653324565,GNG2/GNG5,2
R-HSA-182971,R-HSA-182971,EGFR downregulation,2/331,28/8183,0.313906934706489,0.643121015608606,0.513835653324565,CDC42/UBC,2
R-HSA-70268,R-HSA-70268,Pyruvate metabolism,2/331,28/8183,0.313906934706489,0.643121015608606,0.513835653324565,BSG/PDHB,2
R-HSA-204998,R-HSA-204998,Cell death signalling via NRAGE, NRIF and NADE,4/331,70/8183,0.314050602101867,0.643121015608606,0.513835653324565,BEX3/RAC1/NCSTN/UBC,4
R-HSA-9006936,R-HSA-9006936,Signaling by TGF-beta family members,5/331,92/8183,0.315398580499137,0.644480396594766,0.514921760604825,RHOA/HDAC1/PPP1R15A/JUNB/UBC,5
R-HSA-72163,R-HSA-72163,mRNA Splicing - Major Pathway,9/331,182/8183,0.316260021203819,0.644841861415579,0.515210560858352,SNRPF/POLR2H/SRSF9/LSM3/SNRPE/HNRNPF/LSM5/PAPOLA/TXNL4A,9
R-HSA-381070,R-HSA-381070,IRE1alpha activates chaperones,3/331,49/8183,0.318271843707183,0.647542282445284,0.517368121520145,PDIA6/SERP1/HSPA5,3
R-HSA-9007101,R-HSA-9007101,Rab regulation of trafficking,6/331,116/8183,0.328613528281131,0.654066480202776,0.522580772538815,RAB13/MAP1LC3B/AKT3/GABARAPL2/RAB7A/ARF6,6
R-HSA-114452,R-HSA-114452,Activation of BH3-only proteins,2/331,29/8183,0.328960547351077,0.654066480202776,0.522580772538815,AKT3/DYNLL1,2
R-HSA-2129379,R-HSA-2129379,Molecules associated with elastic fibres,2/331,29/8183,0.328960547351077,0.654066480202776,0.522580772538815,MFAP2/ELN,2
R-HSA-5339562,R-HSA-5339562,Uptake and actions of bacterial toxins,2/331,29/8183,0.328960547351077,0.654066480202776,0.522580772538815,CD9/EEF2,2
R-HSA-977444,R-HSA-977444,GABA B receptor activation,2/331,29/8183,0.328960547351077,0.654066480202776,0.522580772538815,GNG2/GNG5,2
R-HSA-991365,R-HSA-991365,Activation of GABAB receptors,2/331,29/8183,0.328960547351077,0.654066480202776,0.522580772538815,GNG2/GNG5,2
R-HSA-8856825,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,5/331,94/8183,0.331491750988489,0.654066480202776,0.522580772538815,VAMP8/SYT11/AP2M1/SCARB2/UBC,5
R-HSA-8854518,R-HSA-8854518,AURKA Activation by TPX2,4/331,72/8183,0.332573294395179,0.654066480202776,0.522580772538815,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-1170546,R-HSA-1170546,Prolactin receptor signaling,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,RBX1,1
R-HSA-1234158,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,CA9,1
R-HSA-179812,R-HSA-179812,GRB2 events in EGFR signaling,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,HRAS,1
R-HSA-196025,R-HSA-196025,Formation of annular gap junctions,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,AP2M1,1
R-HSA-209776,R-HSA-209776,Amine-derived hormones,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,TPH1,1
R-HSA-3215018,R-HSA-3215018,Processing and activation of SUMO,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,SUMO2,1
R-HSA-3270619,R-HSA-3270619,IRF3-mediated induction of type I IFN,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,PRKDC,1
R-HSA-351906,R-HSA-351906,Apoptotic cleavage of cell adhesion  proteins,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,DSP,1
R-HSA-442729,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,CAMK2B,1
R-HSA-4641265,R-HSA-4641265,Repression of WNT target genes,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,HDAC1,1
R-HSA-5578768,R-HSA-5578768,Physiological factors,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,NPPA,1
R-HSA-8853334,R-HSA-8853334,Signaling by FGFR3 fusions in cancer,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,HRAS,1
R-HSA-9014325,R-HSA-9014325,TICAM1,TRAF6-dependent induction of TAK1 complex,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,UBC,1
R-HSA-937042,R-HSA-937042,IRAK2 mediated activation of TAK1 complex,1/331,10/8183,0.338428724508996,0.654066480202776,0.522580772538815,UBC,1
R-HSA-917937,R-HSA-917937,Iron uptake and transport,3/331,51/8183,0.340689170280606,0.654066480202776,0.522580772538815,FTH1/ATP6AP1/UBC,3
R-HSA-187037,R-HSA-187037,Signaling by NTRK1 (TRKA),4/331,73/8183,0.341857094493332,0.654066480202776,0.522580772538815,RHOA/AP2M1/KIDINS220/HRAS,4
R-HSA-8852135,R-HSA-8852135,Protein ubiquitination,4/331,73/8183,0.341857094493332,0.654066480202776,0.522580772538815,HLA-A/PRKDC/HIST1H2BK/UBC,4
R-HSA-110314,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,2/331,30/8183,0.343922708995551,0.654066480202776,0.522580772538815,RBX1/UBC,2
R-HSA-167238,R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,2/331,30/8183,0.343922708995551,0.654066480202776,0.522580772538815,POLR2H/ELOB,2
R-HSA-167243,R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,2/331,30/8183,0.343922708995551,0.654066480202776,0.522580772538815,POLR2H/ELOB,2
R-HSA-381042,R-HSA-381042,PERK regulates gene expression,2/331,30/8183,0.343922708995551,0.654066480202776,0.522580772538815,HSPA5/DDIT3,2
R-HSA-5694530,R-HSA-5694530,Cargo concentration in the ER,2/331,30/8183,0.343922708995551,0.654066480202776,0.522580772538815,FOLR1/TMED10,2
R-HSA-73886,R-HSA-73886,Chromosome Maintenance,5/331,96/8183,0.347660774428144,0.654066480202776,0.522580772538815,HIST1H4C/TERF2IP/HIST1H2AC/H2AFZ/HIST1H2BK,5
R-HSA-5619115,R-HSA-5619115,Disorders of transmembrane transporters,7/331,142/8183,0.35132581774502,0.654066480202776,0.522580772538815,OS9/PSMB9/PSMB8/PSMD6/PSMD7/PSME1/UBC,7
R-HSA-71406,R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,3/331,52/8183,0.351882859742065,0.654066480202776,0.522580772538815,BSG/PDHB/MDH2,3
R-HSA-9006934,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,18/331,400/8183,0.353798104288371,0.654066480202776,0.522580772538815,SPINT2/RHOA/BRK1/CYBA/ATP6AP1/ELMO1/POLR2H/HGF/CDC42/AKT3/RAC1/NCSTN/HNRNPF/AP2M1/KIDINS220/HRAS/ARF6/UBC,18
R-HSA-187687,R-HSA-187687,Signalling to ERKs,2/331,31/8183,0.358776215769833,0.654066480202776,0.522580772538815,KIDINS220/HRAS,2
R-HSA-2173789,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,2/331,31/8183,0.358776215769833,0.654066480202776,0.522580772538815,PPP1R15A/UBC,2
R-HSA-450282,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/331,31/8183,0.358776215769833,0.654066480202776,0.522580772538815,FOS/JUN,2
R-HSA-5362517,R-HSA-5362517,Signaling by Retinoic Acid,2/331,31/8183,0.358776215769833,0.654066480202776,0.522580772538815,FABP5/PDHB,2
R-HSA-72172,R-HSA-72172,mRNA Splicing,9/331,190/8183,0.362107152285263,0.654066480202776,0.522580772538815,SNRPF/POLR2H/SRSF9/LSM3/SNRPE/HNRNPF/LSM5/PAPOLA/TXNL4A,9
R-HSA-6781823,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,3/331,53/8183,0.363054687711869,0.654066480202776,0.522580772538815,POLR2H/RBX1/UBC,3
R-HSA-1187000,R-HSA-1187000,Fertilization,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,CD9,1
R-HSA-140342,R-HSA-140342,Apoptosis induced DNA fragmentation,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,HIST1H1C,1
R-HSA-174403,R-HSA-174403,Glutathione synthesis and recycling,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,GGCT,1
R-HSA-180336,R-HSA-180336,SHC1 events in EGFR signaling,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,HRAS,1
R-HSA-190873,R-HSA-190873,Gap junction degradation,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,AP2M1,1
R-HSA-193692,R-HSA-193692,Regulated proteolysis of p75NTR,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,NCSTN,1
R-HSA-2022857,R-HSA-2022857,Keratan sulfate degradation,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,HEXB,1
R-HSA-2032785,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,NPPA,1
R-HSA-2160916,R-HSA-2160916,Hyaluronan uptake and degradation,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,HEXB,1
R-HSA-2206281,R-HSA-2206281,Mucopolysaccharidoses,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,IDS,1
R-HSA-2453902,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,RBP1,1
R-HSA-388844,R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,SLITRK6,1
R-HSA-391160,R-HSA-391160,Signal regulatory protein family interactions,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,CD47,1
R-HSA-5655291,R-HSA-5655291,Signaling by FGFR4 in disease,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,HRAS,1
R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,S100A1,1
R-HSA-5689877,R-HSA-5689877,Josephin domain DUBs,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,UBC,1
R-HSA-6804759,R-HSA-6804759,Regulation of TP53 Activity through Association with Co-factors,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,AKT3,1
R-HSA-879415,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,DDOST,1
R-HSA-8934903,R-HSA-8934903,Receptor Mediated Mitophagy,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,MAP1LC3B,1
R-HSA-9013700,R-HSA-9013700,NOTCH4 Activation and Transmission of Signal to the Nucleus,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,NCSTN,1
R-HSA-9013973,R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,UBC,1
R-HSA-9614399,R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,AKT3,1
R-HSA-975110,R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,1/331,11/8183,0.365221835017686,0.654066480202776,0.522580772538815,UBC,1
R-HSA-190236,R-HSA-190236,Signaling by FGFR,4/331,76/8183,0.369731977168518,0.660887139454922,0.528030287976611,POLR2H/HNRNPF/HRAS/UBC,4
R-HSA-167287,R-HSA-167287,HIV elongation arrest and recovery,2/331,32/8183,0.373505396700285,0.661337428056776,0.528390055939876,POLR2H/ELOB,2
R-HSA-167290,R-HSA-167290,Pausing and recovery of HIV elongation,2/331,32/8183,0.373505396700285,0.661337428056776,0.528390055939876,POLR2H/ELOB,2
R-HSA-168274,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,2/331,32/8183,0.373505396700285,0.661337428056776,0.528390055939876,HSPA1A/HSPA1B,2
R-HSA-5673000,R-HSA-5673000,RAF activation,2/331,32/8183,0.373505396700285,0.661337428056776,0.528390055939876,HRAS/CAMK2B,2
R-HSA-5689901,R-HSA-5689901,Metalloprotease DUBs,2/331,32/8183,0.373505396700285,0.661337428056776,0.528390055939876,HIST1H2AC/UBC,2
R-HSA-388841,R-HSA-388841,Costimulation by the CD28 family,3/331,54/8183,0.374196230524694,0.661337428056776,0.528390055939876,CDC42/AKT3/RAC1,3
R-HSA-68877,R-HSA-68877,Mitotic Prometaphase,9/331,193/8183,0.379518592611517,0.669487854382115,0.534902017972077,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/DYNLL1/AKAP9/TUBB4B,9
R-HSA-2559585,R-HSA-2559585,Oncogene Induced Senescence,2/331,33/8183,0.388096018486712,0.669561596735639,0.534960936044231,CDKN2C/UBC,2
R-HSA-5357905,R-HSA-5357905,Regulation of TNFR1 signaling,2/331,33/8183,0.388096018486712,0.669561596735639,0.534960936044231,CLIP3/UBC,2
R-HSA-5654743,R-HSA-5654743,Signaling by FGFR4,2/331,33/8183,0.388096018486712,0.669561596735639,0.534960936044231,HRAS/UBC,2
R-HSA-9022692,R-HSA-9022692,Regulation of MECP2 expression and activity,2/331,33/8183,0.388096018486712,0.669561596735639,0.534960936044231,HDAC1/CAMK2B,2
R-HSA-111932,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,CAMK2B,1
R-HSA-1250347,R-HSA-1250347,SHC1 events in ERBB4 signaling,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,HRAS,1
R-HSA-169893,R-HSA-169893,Prolonged ERK activation events,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,KIDINS220,1
R-HSA-416993,R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,AP2M1,1
R-HSA-451306,R-HSA-451306,Ionotropic activity of kainate receptors,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,GRIK2,1
R-HSA-451308,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,GRIK2,1
R-HSA-5654704,R-HSA-5654704,SHC-mediated cascade:FGFR3,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,HRAS,1
R-HSA-5654719,R-HSA-5654719,SHC-mediated cascade:FGFR4,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,HRAS,1
R-HSA-6785631,R-HSA-6785631,ERBB2 Regulates Cell Motility,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,RHOA,1
R-HSA-74217,R-HSA-74217,Purine salvage,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,APRT,1
R-HSA-8866427,R-HSA-8866427,VLDLR internalisation and degradation,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,AP2M1,1
R-HSA-8963898,R-HSA-8963898,Plasma lipoprotein assembly,1/331,12/8183,0.39093299172463,0.669561596735639,0.534960936044231,P4HB,1
R-HSA-2029480,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,4/331,79/8183,0.397532729755559,0.679301468257351,0.542742820207851,BRK1/ELMO1/CDC42/RAC1,4
R-HSA-381676,R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,2/331,34/8183,0.402535195437341,0.679301468257351,0.542742820207851,GNG2/GNG5,2
R-HSA-5576892,R-HSA-5576892,Phase 0 - rapid depolarisation,2/331,34/8183,0.402535195437341,0.679301468257351,0.542742820207851,CACNA2D1/CAMK2B,2
R-HSA-5654741,R-HSA-5654741,Signaling by FGFR3,2/331,34/8183,0.402535195437341,0.679301468257351,0.542742820207851,HRAS/UBC,2
R-HSA-5655253,R-HSA-5655253,Signaling by FGFR2 in disease,2/331,34/8183,0.402535195437341,0.679301468257351,0.542742820207851,POLR2H/HRAS,2
R-HSA-397014,R-HSA-397014,Muscle contraction,7/331,150/8183,0.40477126480575,0.679301468257351,0.542742820207851,MYL6/MYL12B/CACNA2D1/TPM3/NPPA/CAMK2B/AKAP9,7
R-HSA-72187,R-HSA-72187,mRNA 3'-end processing,3/331,57/8183,0.407360660910726,0.679301468257351,0.542742820207851,THOC7/SRSF9/PAPOLA,3
R-HSA-8986944,R-HSA-8986944,Transcriptional Regulation by MECP2,3/331,57/8183,0.407360660910726,0.679301468257351,0.542742820207851,SGK1/HDAC1/CAMK2B,3
R-HSA-112308,R-HSA-112308,Presynaptic depolarization and calcium channel opening,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,CACNA2D1,1
R-HSA-1362409,R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,GLRX5,1
R-HSA-171007,R-HSA-171007,p38MAPK events,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,HRAS,1
R-HSA-1834941,R-HSA-1834941,STING mediated induction of host immune responses,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,PRKDC,1
R-HSA-1855183,R-HSA-1855183,Synthesis of IP2, IP, and Ins in the cytosol,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,IMPA2,1
R-HSA-1963640,R-HSA-1963640,GRB2 events in ERBB2 signaling,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,HRAS,1
R-HSA-209543,R-HSA-209543,p75NTR recruits signalling complexes,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,UBC,1
R-HSA-209560,R-HSA-209560,NF-kB is activated and signals survival,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,UBC,1
R-HSA-2559584,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,HIST1H1C,1
R-HSA-3134975,R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,UBC,1
R-HSA-399955,R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,RAC1,1
R-HSA-428540,R-HSA-428540,Activation of RAC1,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,RAC1,1
R-HSA-5099900,R-HSA-5099900,WNT5A-dependent internalization of FZD4,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,AP2M1,1
R-HSA-5140745,R-HSA-5140745,WNT5A-dependent internalization of FZD2, FZD5 and ROR2,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,AP2M1,1
R-HSA-71336,R-HSA-71336,Pentose phosphate pathway,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,TKT,1
R-HSA-9027284,R-HSA-9027284,Erythropoietin activates RAS,1/331,13/8183,0.415605758795876,0.679301468257351,0.542742820207851,HRAS,1
R-HSA-380270,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,4/331,81/8183,0.415960406556722,0.679301468257351,0.542742820207851,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-380287,R-HSA-380287,Centrosome maturation,4/331,81/8183,0.415960406556722,0.679301468257351,0.542742820207851,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-1566948,R-HSA-1566948,Elastic fibre formation,2/331,35/8183,0.416811304302281,0.679301468257351,0.542742820207851,MFAP2/ELN,2
R-HSA-432040,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,2/331,35/8183,0.416811304302281,0.679301468257351,0.542742820207851,GNG2/GNG5,2
R-HSA-1834949,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,3/331,58/8183,0.418304460679069,0.680557516337968,0.543746367394845,POLR2H/PRKDC/UBC,3
R-HSA-3700989,R-HSA-3700989,Transcriptional Regulation by TP53,15/331,344/8183,0.42000905962325,0.682152645112244,0.545020830545596,COX7C/CDKN1A/FOS/POLR2H/COX4I1/ELOB/SGK1/AKT3/COX6C/HDAC1/RHEB/CHD4/JUN/BTG2/UBC,15
R-HSA-5693571,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),3/331,59/8183,0.429181539347287,0.688482618964061,0.550078302111189,HIST1H4C/PRKDC/HIST1H2BK,3
R-HSA-5689896,R-HSA-5689896,Ovarian tumor domain proteases,2/331,36/8183,0.430913903758388,0.688482618964061,0.550078302111189,RHOA/UBC,2
R-HSA-8875878,R-HSA-8875878,MET promotes cell motility,2/331,36/8183,0.430913903758388,0.688482618964061,0.550078302111189,HGF/RAC1,2
R-HSA-174490,R-HSA-174490,Membrane binding and targetting of GAG proteins,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,UBC,1
R-HSA-174495,R-HSA-174495,Synthesis And Processing Of GAG, GAGPOL Polyproteins,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,UBC,1
R-HSA-177504,R-HSA-177504,Retrograde neurotrophin signalling,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,AP2M1,1
R-HSA-210745,R-HSA-210745,Regulation of gene expression in beta cells,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,AKT3,1
R-HSA-2142845,R-HSA-2142845,Hyaluronan metabolism,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HEXB,1
R-HSA-5637810,R-HSA-5637810,Constitutive Signaling by EGFRvIII,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-5637812,R-HSA-5637812,Signaling by EGFRvIII in Cancer,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-5654688,R-HSA-5654688,SHC-mediated cascade:FGFR1,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-5654699,R-HSA-5654699,SHC-mediated cascade:FGFR2,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-5654706,R-HSA-5654706,FRS-mediated FGFR3 signaling,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-5654712,R-HSA-5654712,FRS-mediated FGFR4 signaling,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HRAS,1
R-HSA-6804116,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,CDKN1A,1
R-HSA-9005891,R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HDAC1,1
R-HSA-9005895,R-HSA-9005895,Pervasive developmental disorders,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HDAC1,1
R-HSA-9022699,R-HSA-9022699,MECP2 regulates neuronal receptors and channels,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,HDAC1,1
R-HSA-937039,R-HSA-937039,IRAK1 recruits IKK complex,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,UBC,1
R-HSA-975144,R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,UBC,1
R-HSA-975163,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,1/331,14/8183,0.439281951432175,0.688482618964061,0.550078302111189,UBC,1
R-HSA-6790901,R-HSA-6790901,rRNA modification in the nucleus and cytosol,3/331,60/8183,0.439985707660684,0.688482618964061,0.550078302111189,RPS9/RPS14/TRMT112,3
R-HSA-5688426,R-HSA-5688426,Deubiquitination,11/331,255/8183,0.457612338780059,0.704216192456309,0.562648986038955,RHOA/UCHL1/PSMB9/PSMB8/HIST1H2AC/PSMD6/PSMD7/SNX3/PSME1/HIST1H2BK/UBC,11
R-HSA-1660662,R-HSA-1660662,Glycosphingolipid metabolism,2/331,38/8183,0.458562266384236,0.704216192456309,0.562648986038955,PSAP/HEXB,2
R-HSA-418597,R-HSA-418597,G alpha (z) signalling events,2/331,38/8183,0.458562266384236,0.704216192456309,0.562648986038955,GNG2/GNG5,2
R-HSA-445717,R-HSA-445717,Aquaporin-mediated transport,2/331,38/8183,0.458562266384236,0.704216192456309,0.562648986038955,GNG2/GNG5,2
R-HSA-5696394,R-HSA-5696394,DNA Damage Recognition in GG-NER,2/331,38/8183,0.458562266384236,0.704216192456309,0.562648986038955,RBX1/UBC,2
R-HSA-8856828,R-HSA-8856828,Clathrin-mediated endocytosis,6/331,134/8183,0.459407686446347,0.704216192456309,0.562648986038955,VAMP8/SYT11/AP2M1/SCARB2/ARF6/UBC,6
R-HSA-69620,R-HSA-69620,Cell Cycle Checkpoints,12/331,280/8183,0.46096772940607,0.704216192456309,0.562648986038955,RPS27/HIST1H4C/PSMB9/PSMB8/CDKN1A/MAD1L1/PSMD6/PSMD7/DYNLL1/PSME1/HIST1H2BK/UBC,12
R-HSA-111447,R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,AKT3,1
R-HSA-204174,R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,PDHB,1
R-HSA-2691230,R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,UBC,1
R-HSA-2691232,R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,UBC,1
R-HSA-5635838,R-HSA-5635838,Activation of SMO,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,EVC2,1
R-HSA-70221,R-HSA-70221,Glycogen breakdown (glycogenolysis),1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,GYG1,1
R-HSA-8875360,R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,UBC,1
R-HSA-937072,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,UBC,1
R-HSA-9614657,R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/331,15/8183,0.46200170587898,0.704216192456309,0.562648986038955,DDIT3,1
R-HSA-450294,R-HSA-450294,MAP kinase activation,3/331,63/8183,0.47190406455461,0.714330628427839,0.570730136692261,FOS/JUN/UBC,3
R-HSA-6802952,R-HSA-6802952,Signaling by BRAF and RAF fusions,3/331,63/8183,0.47190406455461,0.714330628427839,0.570730136692261,HRAS/CAMK2B/AKAP9,3
R-HSA-418555,R-HSA-418555,G alpha (s) signalling events,5/331,112/8183,0.476369514202089,0.714330628427839,0.570730136692261,RAMP1/OR51E1/GNG2/GNG5/CALCB,5
R-HSA-5693607,R-HSA-5693607,Processing of DNA double-strand break ends,4/331,88/8183,0.479246878864826,0.714330628427839,0.570730136692261,HIST1H4C/SUMO2/HIST1H2BK/UBC,4
R-HSA-6782210,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,3/331,64/8183,0.482361585376395,0.714330628427839,0.570730136692261,POLR2H/RBX1/UBC,3
R-HSA-110312,R-HSA-110312,Translesion synthesis by REV1,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-1295596,R-HSA-1295596,Spry regulation of FGF signaling,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-1362300,R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HDAC1,1
R-HSA-175474,R-HSA-175474,Assembly Of The HIV Virion,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-193639,R-HSA-193639,p75NTR signals via NF-kB,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-399954,R-HSA-399954,Sema3A PAK dependent Axon repulsion,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,RAC1,1
R-HSA-399956,R-HSA-399956,CRMPs in Sema3A signaling,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,DPYSL3,1
R-HSA-5654693,R-HSA-5654693,FRS-mediated FGFR1 signaling,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HRAS,1
R-HSA-5654700,R-HSA-5654700,FRS-mediated FGFR2 signaling,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HRAS,1
R-HSA-5655332,R-HSA-5655332,Signaling by FGFR3 in disease,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HRAS,1
R-HSA-5684264,R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-8853338,R-HSA-8853338,Signaling by FGFR3 point mutants in cancer,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HRAS,1
R-HSA-9034015,R-HSA-9034015,Signaling by NTRK3 (TRKC),1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,HRAS,1
R-HSA-936964,R-HSA-936964,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,UBC,1
R-HSA-9617828,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/331,16/8183,0.483803546642209,0.714330628427839,0.570730136692261,CDKN1A,1
R-HSA-6811442,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,8/331,187/8183,0.487326126145199,0.71840565074926,0.573985965231558,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/TMED10/ARF4/TUBB4B,8
R-HSA-5693565,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,3/331,65/8183,0.492720343332129,0.724091362587934,0.578528689518798,HIST1H4C/HIST1H2BK/UBC,3
R-HSA-6782135,R-HSA-6782135,Dual incision in TC-NER,3/331,65/8183,0.492720343332129,0.724091362587934,0.578528689518798,POLR2H/RBX1/UBC,3
R-HSA-1433557,R-HSA-1433557,Signaling by SCF-KIT,2/331,41/8183,0.498532304590247,0.728101734857219,0.581732864479732,RAC1/HRAS,2
R-HSA-373752,R-HSA-373752,Netrin-1 signaling,2/331,41/8183,0.498532304590247,0.728101734857219,0.581732864479732,CDC42/RAC1,2
R-HSA-5696400,R-HSA-5696400,Dual Incision in GG-NER,2/331,41/8183,0.498532304590247,0.728101734857219,0.581732864479732,RBX1/UBC,2
R-HSA-388396,R-HSA-388396,GPCR downstream signalling,19/331,461/8183,0.501011096565837,0.728101734857219,0.581732864479732,TAC3/GRP/RHOA/RAMP1/RGS7/RBP1/OR51E1/GNG2/PSAP/NPW/GNRH2/CDC42/RGS2/AKT3/RHOB/HRAS/CAMK2B/GNG5/CALCB,19
R-HSA-72203,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,10/331,239/8183,0.502836390138453,0.728101734857219,0.581732864479732,THOC7/SNRPF/POLR2H/SRSF9/LSM3/SNRPE/HNRNPF/LSM5/PAPOLA/TXNL4A,10
R-HSA-5693606,R-HSA-5693606,DNA Double Strand Break Response,3/331,66/8183,0.502976128224971,0.728101734857219,0.581732864479732,HIST1H4C/HIST1H2BK/UBC,3
R-HSA-163560,R-HSA-163560,Triglyceride catabolism,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,FABP5,1
R-HSA-3232118,R-HSA-3232118,SUMOylation of transcription factors,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,SUMO2,1
R-HSA-5655862,R-HSA-5655862,Translesion synthesis by POLK,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,UBC,1
R-HSA-5656121,R-HSA-5656121,Translesion synthesis by POLI,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,UBC,1
R-HSA-5675482,R-HSA-5675482,Regulation of necroptotic cell death,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,UBC,1
R-HSA-881907,R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,1/331,17/8183,0.504724451020981,0.728101734857219,0.581732864479732,HRAS,1
R-HSA-5617833,R-HSA-5617833,Cilium Assembly,8/331,190/8183,0.505501469179486,0.728107620744764,0.581737567138794,TUBB2B/TUBA1A/TUBB2A/TUBB3/DYNLL1/ARF4/AKAP9/TUBB4B,8
R-HSA-167169,R-HSA-167169,HIV Transcription Elongation,2/331,42/8183,0.511431689954929,0.731060169859702,0.584096571069043,POLR2H/ELOB,2
R-HSA-167200,R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,2/331,42/8183,0.511431689954929,0.731060169859702,0.584096571069043,POLR2H/ELOB,2
R-HSA-167246,R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,2/331,42/8183,0.511431689954929,0.731060169859702,0.584096571069043,POLR2H/ELOB,2
R-HSA-379724,R-HSA-379724,tRNA Aminoacylation,2/331,42/8183,0.511431689954929,0.731060169859702,0.584096571069043,EEF1E1/EPRS,2
R-HSA-5654736,R-HSA-5654736,Signaling by FGFR1,2/331,42/8183,0.511431689954929,0.731060169859702,0.584096571069043,HRAS/UBC,2
R-HSA-4551638,R-HSA-4551638,SUMOylation of chromatin organization proteins,3/331,67/8183,0.513125029379576,0.732369360114486,0.585142577362674,HIST1H4C/SUMO2/HDAC1,3
R-HSA-163685,R-HSA-163685,Integration of energy metabolism,4/331,92/8183,0.51421427111369,0.732813681375334,0.585497577587847,GNG2/GNG5/TKT/ADIPOR1,4
R-HSA-375276,R-HSA-375276,Peptide ligand-binding receptors,4/331,93/8183,0.522788675588249,0.737853009287128,0.589523859247175,TAC3/GRP/PSAP/NPW,4
R-HSA-6802946,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,2/331,43/8183,0.524111680534662,0.737853009287128,0.589523859247175,HRAS/CAMK2B,2
R-HSA-6802955,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,2/331,43/8183,0.524111680534662,0.737853009287128,0.589523859247175,HRAS/CAMK2B,2
R-HSA-75893,R-HSA-75893,TNF signaling,2/331,43/8183,0.524111680534662,0.737853009287128,0.589523859247175,CLIP3/UBC,2
R-HSA-168927,R-HSA-168927,TICAM1, RIP1-mediated IKK complex recruitment ,1/331,18/8183,0.524799911064094,0.737853009287128,0.589523859247175,UBC,1
R-HSA-389513,R-HSA-389513,CTLA4 inhibitory signaling,1/331,18/8183,0.524799911064094,0.737853009287128,0.589523859247175,AKT3,1
R-HSA-4641263,R-HSA-4641263,Regulation of FZD by ubiquitination,1/331,18/8183,0.524799911064094,0.737853009287128,0.589523859247175,UBC,1
R-HSA-5620916,R-HSA-5620916,VxPx cargo-targeting to cilium,1/331,18/8183,0.524799911064094,0.737853009287128,0.589523859247175,ARF4,1
R-HSA-73780,R-HSA-73780,RNA Polymerase III Chain Elongation,1/331,18/8183,0.524799911064094,0.737853009287128,0.589523859247175,POLR2H,1
R-HSA-73894,R-HSA-73894,DNA Repair,13/331,318/8183,0.52559291233762,0.737866651895735,0.589534759308806,HIST1H4C/TERF2IP/HIST1H2AC/POLR2H/SUMO2/BPHL/H2AFZ/RBX1/PRKDC/NTHL1/APEX1/HIST1H2BK/UBC,13
R-HSA-8951664,R-HSA-8951664,Neddylation,9/331,220/8183,0.535029344953383,0.741690711223932,0.592590075455483,PSMB9/PSMB8/PSMD6/ELOB/PSMD7/RNF7/RBX1/PSME1/UBC,9
R-HSA-167152,R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,2/331,44/8183,0.536568877434119,0.741690711223932,0.592590075455483,POLR2H/ELOB,2
R-HSA-68875,R-HSA-68875,Mitotic Prophase,5/331,120/8183,0.537812033862205,0.741690711223932,0.592590075455483,HIST1H4C/HIST1H2AC/H3F3A/H2AFZ/HIST1H2BK,5
R-HSA-1169408,R-HSA-1169408,ISG15 antiviral mechanism,3/331,70/8183,0.542895624372985,0.741690711223932,0.592590075455483,EIF4A2/EIF4A1/UBC,3
R-HSA-110320,R-HSA-110320,Translesion Synthesis by POLH,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,UBC,1
R-HSA-1250196,R-HSA-1250196,SHC1 events in ERBB2 signaling,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HRAS,1
R-HSA-1362277,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HDAC1,1
R-HSA-1592389,R-HSA-1592389,Activation of Matrix Metalloproteinases,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,TIMP1,1
R-HSA-389357,R-HSA-389357,CD28 dependent PI3K/Akt signaling,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,AKT3,1
R-HSA-3928664,R-HSA-3928664,Ephrin signaling,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,RAC1,1
R-HSA-5213460,R-HSA-5213460,RIPK1-mediated regulated necrosis,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,UBC,1
R-HSA-5218859,R-HSA-5218859,Regulated Necrosis,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,UBC,1
R-HSA-5218921,R-HSA-5218921,VEGFR2 mediated cell proliferation,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HRAS,1
R-HSA-5621575,R-HSA-5621575,CD209 (DC-SIGN) signaling,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HRAS,1
R-HSA-5654708,R-HSA-5654708,Downstream signaling of activated FGFR3,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HRAS,1
R-HSA-5654716,R-HSA-5654716,Downstream signaling of activated FGFR4,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,HRAS,1
R-HSA-6804760,R-HSA-6804760,Regulation of TP53 Activity through Methylation,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,UBC,1
R-HSA-77595,R-HSA-77595,Processing of Intronless Pre-mRNAs,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,PAPOLA,1
R-HSA-8851708,R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,POLR2H,1
R-HSA-8876725,R-HSA-8876725,Protein methylation,1/331,19/8183,0.544063993052799,0.741690711223932,0.592590075455483,EEF2,1
R-HSA-5620912,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,4/331,96/8183,0.54806842410107,0.74607002240348,0.596089022257781,TUBA1A/DYNLL1/AKAP9/TUBB4B,4
R-HSA-9012852,R-HSA-9012852,Signaling by NOTCH3,2/331,46/8183,0.560804405906476,0.757030756744381,0.604846341571385,NCSTN/UBC,2
R-HSA-156584,R-HSA-156584,Cytosolic sulfonation of small molecules,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,PODXL2,1
R-HSA-167044,R-HSA-167044,Signalling to RAS,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,HRAS,1
R-HSA-390522,R-HSA-390522,Striated Muscle Contraction,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,TPM3,1
R-HSA-445144,R-HSA-445144,Signal transduction by L1,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,RAC1,1
R-HSA-6803157,R-HSA-6803157,Antimicrobial peptides,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,CHGA,1
R-HSA-6804115,R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,BTG2,1
R-HSA-8876384,R-HSA-8876384,Listeria monocytogenes entry into host cells,1/331,20/8183,0.562549394608351,0.757030756744381,0.604846341571385,UBC,1
R-HSA-425407,R-HSA-425407,SLC-mediated transmembrane transport,7/331,175/8183,0.566926719461719,0.761833052400769,0.608683241106883,APOD/BSG/LCN15/SLC25A6/LCN12/ARL2/SLC29A1,7
R-HSA-1852241,R-HSA-1852241,Organelle biogenesis and maintenance,11/331,277/8183,0.569612689614759,0.764352070679634,0.610695866058709,TUBB2B/TUBA1A/ATP5F1E/TUBB2A/TUBB3/ATP5PO/DYNLL1/ARF4/ATP5ME/AKAP9/TUBB4B,11
R-HSA-446728,R-HSA-446728,Cell junction organization,3/331,73/8183,0.571590307906507,0.765018452979424,0.611228286825665,CLDN18/CDH18/CLDN7,3
R-HSA-1793185,R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,2/331,47/8183,0.57257891790179,0.765018452979424,0.611228286825665,HEXB/IDS,2
R-HSA-381038,R-HSA-381038,XBP1(S) activates chaperone genes,2/331,47/8183,0.57257891790179,0.765018452979424,0.611228286825665,PDIA6/SERP1,2
R-HSA-500792,R-HSA-500792,GPCR ligand binding,9/331,227/8183,0.573357778984579,0.765018452979424,0.611228286825665,TAC3/GRP/RAMP1/GNG2/PSAP/NPW/GNRH2/GNG5/CALCB,9
R-HSA-2024096,R-HSA-2024096,HS-GAG degradation,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,IDS,1
R-HSA-210991,R-HSA-210991,Basigin interactions,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,BSG,1
R-HSA-3238698,R-HSA-3238698,WNT ligand biogenesis and trafficking,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,SNX3,1
R-HSA-5651801,R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,APEX1,1
R-HSA-5654696,R-HSA-5654696,Downstream signaling of activated FGFR2,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,HRAS,1
R-HSA-6783783,R-HSA-6783783,Interleukin-10 signaling,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,TIMP1,1
R-HSA-8956321,R-HSA-8956321,Nucleotide salvage,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,APRT,1
R-HSA-912631,R-HSA-912631,Regulation of signaling by CBL,1/331,21/8183,0.580287499518878,0.765589390121546,0.611684449588675,UBC,1
R-HSA-109606,R-HSA-109606,Intrinsic Pathway for Apoptosis,2/331,48/8183,0.584122914289098,0.766356246880683,0.612297146630561,AKT3/DYNLL1,2
R-HSA-6791312,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,2/331,48/8183,0.584122914289098,0.766356246880683,0.612297146630561,CDKN1A/BTG2,2
R-HSA-73893,R-HSA-73893,DNA Damage Bypass,2/331,48/8183,0.584122914289098,0.766356246880683,0.612297146630561,RBX1/UBC,2
R-HSA-75153,R-HSA-75153,Apoptotic execution phase,2/331,48/8183,0.584122914289098,0.766356246880683,0.612297146630561,HIST1H1C/DSP,2
R-HSA-9609507,R-HSA-9609507,Protein localization,6/331,153/8183,0.58969042159257,0.772584669179696,0.617273481353763,CYB5A/SEC61G/TOMM7/SERP1/SLC25A6/UBC,6
R-HSA-1500931,R-HSA-1500931,Cell-Cell communication,4/331,102/8183,0.596441631090493,0.773953977186502,0.618367520045088,CLDN18/CDH18/CD47/CLDN7,4
R-HSA-1251985,R-HSA-1251985,Nuclear signaling by ERBB4,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,NCSTN,1
R-HSA-450321,R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,UBC,1
R-HSA-71403,R-HSA-71403,Citric acid cycle (TCA cycle),1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,MDH2,1
R-HSA-77387,R-HSA-77387,Insulin receptor recycling,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,ATP6AP1,1
R-HSA-9006335,R-HSA-9006335,Signaling by Erythropoietin,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,HRAS,1
R-HSA-937041,R-HSA-937041,IKK complex recruitment mediated by RIP1,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,UBC,1
R-HSA-9615017,R-HSA-9615017,FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes,1/331,22/8183,0.59730843037642,0.773953977186502,0.618367520045088,HDAC1,1
R-HSA-1169410,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,3/331,77/8183,0.608070849460545,0.785393906743003,0.627507702895572,EIF4A2/EIF4A1/UBC,3
R-HSA-166208,R-HSA-166208,mTORC1-mediated signalling,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,RHEB,1
R-HSA-167242,R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,POLR2H,1
R-HSA-174048,R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,UBC,1
R-HSA-381753,R-HSA-381753,Olfactory Signaling Pathway,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,OR51E1,1
R-HSA-450302,R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,UBC,1
R-HSA-5654732,R-HSA-5654732,Negative regulation of FGFR3 signaling,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,UBC,1
R-HSA-5654733,R-HSA-5654733,Negative regulation of FGFR4 signaling,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,UBC,1
R-HSA-73980,R-HSA-73980,RNA Polymerase III Transcription Termination,1/331,23/8183,0.613641099111306,0.785393906743003,0.627507702895572,POLR2H,1
R-HSA-428157,R-HSA-428157,Sphingolipid metabolism,3/331,78/8183,0.616862389052651,0.786311732730172,0.628241020116296,PSAP/HEXB/SPTSSA,3
R-HSA-6781827,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),3/331,78/8183,0.616862389052651,0.786311732730172,0.628241020116296,POLR2H/RBX1/UBC,3
R-HSA-6802957,R-HSA-6802957,Oncogenic MAPK signaling,3/331,78/8183,0.616862389052651,0.786311732730172,0.628241020116296,HRAS/CAMK2B/AKAP9,3
R-HSA-5576891,R-HSA-5576891,Cardiac conduction,4/331,105/8183,0.619443201242205,0.788534453473185,0.630016911647477,CACNA2D1/NPPA/CAMK2B/AKAP9,4
R-HSA-191859,R-HSA-191859,snRNP Assembly,2/331,52/8183,0.627986608138648,0.792530864556424,0.63320993201234,SNRPF/SNRPE,2
R-HSA-194441,R-HSA-194441,Metabolism of non-coding RNA,2/331,52/8183,0.627986608138648,0.792530864556424,0.63320993201234,SNRPF/SNRPE,2
R-HSA-1266695,R-HSA-1266695,Interleukin-7 signaling,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,HGF,1
R-HSA-1614635,R-HSA-1614635,Sulfur amino acid metabolism,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,ADI1,1
R-HSA-1839126,R-HSA-1839126,FGFR2 mutant receptor activation,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,POLR2H,1
R-HSA-203927,R-HSA-203927,MicroRNA (miRNA) biogenesis,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,POLR2H,1
R-HSA-4090294,R-HSA-4090294,SUMOylation of intracellular receptors,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,SUMO2,1
R-HSA-5654687,R-HSA-5654687,Downstream signaling of activated FGFR1,1/331,24/8183,0.629313255507649,0.792530864556424,0.63320993201234,HRAS,1
R-HSA-111885,R-HSA-111885,Opioid Signalling,3/331,80/8183,0.634043251089307,0.79635832336817,0.636267964251024,GNG2/CAMK2B/GNG5,3
R-HSA-5668914,R-HSA-5668914,Diseases of metabolism,3/331,80/8183,0.634043251089307,0.79635832336817,0.636267964251024,GYG1/IDS/UBC,3
R-HSA-4086398,R-HSA-4086398,Ca2+ pathway,2/331,53/8183,0.638376095214208,0.797607286230078,0.637265850546995,GNG2/GNG5,2
R-HSA-6809371,R-HSA-6809371,Formation of the cornified envelope,2/331,53/8183,0.638376095214208,0.797607286230078,0.637265850546995,KRT12/DSP,2
R-HSA-168142,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,3/331,81/8183,0.642431052802099,0.797607286230078,0.637265850546995,FOS/JUN/UBC,3
R-HSA-168176,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,3/331,81/8183,0.642431052802099,0.797607286230078,0.637265850546995,FOS/JUN/UBC,3
R-HSA-975871,R-HSA-975871,MyD88 cascade initiated on plasma membrane,3/331,81/8183,0.642431052802099,0.797607286230078,0.637265850546995,FOS/JUN/UBC,3
R-HSA-179409,R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,UBC,1
R-HSA-380994,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,DDIT3,1
R-HSA-418990,R-HSA-418990,Adherens junctions interactions,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,CDH18,1
R-HSA-525793,R-HSA-525793,Myogenesis,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,CDC42,1
R-HSA-5654727,R-HSA-5654727,Negative regulation of FGFR2 signaling,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,UBC,1
R-HSA-5696397,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,1/331,25/8183,0.64435153378035,0.797607286230078,0.637265850546995,UBC,1
R-HSA-1226099,R-HSA-1226099,Signaling by FGFR in disease,2/331,54/8183,0.648536859240728,0.80173454252594,0.64056341256682,POLR2H/HRAS,2
R-HSA-2672351,R-HSA-2672351,Stimuli-sensing channels,3/331,82/8183,0.650683036859379,0.803333447865708,0.641840893087475,ANO10/SGK1/UBC,3
R-HSA-5696398,R-HSA-5696398,Nucleotide Excision Repair,4/331,110/8183,0.65591144783289,0.803849961720189,0.642253573170114,POLR2H/SUMO2/RBX1/UBC,4
R-HSA-2219530,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/331,55/8183,0.658470346401696,0.803849961720189,0.642253573170114,HGF/RAC1,2
R-HSA-6802949,R-HSA-6802949,Signaling by RAS mutants,2/331,55/8183,0.658470346401696,0.803849961720189,0.642253573170114,HRAS/CAMK2B,2
R-HSA-1222556,R-HSA-1222556,ROS and RNS production in phagocytes,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,CYBA,1
R-HSA-1483191,R-HSA-1483191,Synthesis of PC,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,MFSD2A,1
R-HSA-264876,R-HSA-264876,Insulin processing,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,CPE,1
R-HSA-5601884,R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,POLR2H,1
R-HSA-5654726,R-HSA-5654726,Negative regulation of FGFR1 signaling,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,UBC,1
R-HSA-8874081,R-HSA-8874081,MET activates PTK2 signaling,1/331,26/8183,0.658781497290855,0.803849961720189,0.642253573170114,HGF,1
R-HSA-5696399,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),3/331,84/8183,0.666778307644411,0.808515653157057,0.645981329765668,SUMO2/RBX1/UBC,3
R-HSA-975138,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,3/331,84/8183,0.666778307644411,0.808515653157057,0.645981329765668,FOS/JUN/UBC,3
R-HSA-432722,R-HSA-432722,Golgi Associated Vesicle Biogenesis,2/331,56/8183,0.668178259719768,0.808515653157057,0.645981329765668,FTH1/VAMP8,2
R-HSA-1538133,R-HSA-1538133,G0 and Early G1,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,HDAC1,1
R-HSA-167160,R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,POLR2H,1
R-HSA-389661,R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,PDHB,1
R-HSA-76066,R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,POLR2H,1
R-HSA-77075,R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,POLR2H,1
R-HSA-8979227,R-HSA-8979227,Triglyceride metabolism,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,FABP5,1
R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,1/331,27/8183,0.672627681475817,0.808515653157057,0.645981329765668,CFHR1,1
R-HSA-168181,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,3/331,85/8183,0.674621341169264,0.808515653157057,0.645981329765668,FOS/JUN/UBC,3
R-HSA-199418,R-HSA-199418,Negative regulation of the PI3K/AKT network,3/331,85/8183,0.674621341169264,0.808515653157057,0.645981329765668,HGF/AKT3/RAC1,3
R-HSA-8876198,R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,3/331,85/8183,0.674621341169264,0.808515653157057,0.645981329765668,RAB13/AKT3/RAB7A,3
R-HSA-975155,R-HSA-975155,MyD88 dependent cascade initiated on endosome,3/331,85/8183,0.674621341169264,0.808515653157057,0.645981329765668,FOS/JUN/UBC,3
R-HSA-112382,R-HSA-112382,Formation of RNA Pol II elongation complex ,2/331,57/8183,0.677662536040097,0.809072381431903,0.646426140042252,POLR2H/ELOB,2
R-HSA-75955,R-HSA-75955,RNA Polymerase II Transcription Elongation,2/331,57/8183,0.677662536040097,0.809072381431903,0.646426140042252,POLR2H/ELOB,2
R-HSA-8873719,R-HSA-8873719,RAB geranylgeranylation,2/331,57/8183,0.677662536040097,0.809072381431903,0.646426140042252,RAB13/RAB7A,2
R-HSA-350054,R-HSA-350054,Notch-HLH transcription pathway,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,HDAC1,1
R-HSA-380972,R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,RHEB,1
R-HSA-69205,R-HSA-69205,G1/S-Specific Transcription,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,HDAC1,1
R-HSA-76061,R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,POLR2H,1
R-HSA-76071,R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,POLR2H,1
R-HSA-917977,R-HSA-917977,Transferrin endocytosis and recycling,1/331,28/8183,0.685913635059865,0.812742948712444,0.649358820347969,ATP6AP1,1
R-HSA-1592230,R-HSA-1592230,Mitochondrial biogenesis,3/331,87/8183,0.689898600905736,0.816437791524125,0.652310896122192,ATP5F1E/ATP5PO/ATP5ME,3
R-HSA-1483166,R-HSA-1483166,Synthesis of PA,1/331,29/8183,0.698661959620894,0.821647398205845,0.656473225742741,AGPAT2,1
R-HSA-162588,R-HSA-162588,Budding and maturation of HIV virion,1/331,29/8183,0.698661959620894,0.821647398205845,0.656473225742741,UBC,1
R-HSA-186712,R-HSA-186712,Regulation of beta-cell development,1/331,29/8183,0.698661959620894,0.821647398205845,0.656473225742741,AKT3,1
R-HSA-186763,R-HSA-186763,Downstream signal transduction,1/331,29/8183,0.698661959620894,0.821647398205845,0.656473225742741,HRAS,1
R-HSA-72086,R-HSA-72086,mRNA Capping,1/331,29/8183,0.698661959620894,0.821647398205845,0.656473225742741,POLR2H,1
R-HSA-373076,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),5/331,145/8183,0.70420106364118,0.822559727597216,0.657202151337591,TAC3/GRP/PSAP/NPW/GNRH2,5
R-HSA-166058,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,3/331,89/8183,0.704632781894725,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-168138,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,3/331,89/8183,0.704632781894725,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-168188,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,3/331,89/8183,0.704632781894725,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-163125,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,2/331,60/8183,0.70479597493748,0.822559727597216,0.657202151337591,NRN1/LY6E,2
R-HSA-983712,R-HSA-983712,Ion channel transport,5/331,146/8183,0.709903109660439,0.822559727597216,0.657202151337591,ATP6AP1/ANO10/SGK1/CAMK2B/UBC,5
R-HSA-1638074,R-HSA-1638074,Keratan sulfate/keratin metabolism,1/331,30/8183,0.710894347573492,0.822559727597216,0.657202151337591,HEXB,1
R-HSA-445989,R-HSA-445989,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,1/331,30/8183,0.710894347573492,0.822559727597216,0.657202151337591,UBC,1
R-HSA-5357956,R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/331,30/8183,0.710894347573492,0.822559727597216,0.657202151337591,UBC,1
R-HSA-8866652,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/331,30/8183,0.710894347573492,0.822559727597216,0.657202151337591,UBC,1
R-HSA-975634,R-HSA-975634,Retinoid metabolism and transport,1/331,30/8183,0.710894347573492,0.822559727597216,0.657202151337591,RBP1,1
R-HSA-168164,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,3/331,90/8183,0.711797398510467,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-168179,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,3/331,90/8183,0.711797398510467,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-181438,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,3/331,90/8183,0.711797398510467,0.822559727597216,0.657202151337591,FOS/JUN/UBC,3
R-HSA-1268020,R-HSA-1268020,Mitochondrial protein import,2/331,61/8183,0.713409020644295,0.822559727597216,0.657202151337591,TOMM7/SLC25A6,2
R-HSA-211945,R-HSA-211945,Phase I - Functionalization of compounds,2/331,61/8183,0.713409020644295,0.822559727597216,0.657202151337591,BPHL/PTGES3,2
R-HSA-216083,R-HSA-216083,Integrin cell surface interactions,2/331,62/8183,0.721810911346062,0.830145103357151,0.663262653816475,BSG/CD47,2
R-HSA-74752,R-HSA-74752,Signaling by Insulin receptor,2/331,62/8183,0.721810911346062,0.830145103357151,0.663262653816475,ATP6AP1/HRAS,2
R-HSA-73863,R-HSA-73863,RNA Polymerase I Transcription Termination,1/331,31/8183,0.722631618633614,0.830145103357151,0.663262653816475,POLR2H,1
R-HSA-5693567,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),4/331,122/8183,0.733534569454387,0.835343979496176,0.667416410034379,HIST1H4C/SUMO2/HIST1H2BK/UBC,4
R-HSA-8957322,R-HSA-8957322,Metabolism of steroids,4/331,122/8183,0.733534569454387,0.835343979496176,0.667416410034379,TSPO/SUMO2/AKR1B1/HSD17B11,4
R-HSA-163841,R-HSA-163841,Gamma carboxylation, hypusine formation and arylsulfatase activation,1/331,32/8183,0.733893754825011,0.835343979496176,0.667416410034379,EEF2,1
R-HSA-5656169,R-HSA-5656169,Termination of translesion DNA synthesis,1/331,32/8183,0.733893754825011,0.835343979496176,0.667416410034379,UBC,1
R-HSA-6802948,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,1/331,32/8183,0.733893754825011,0.835343979496176,0.667416410034379,HRAS,1
R-HSA-917729,R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),1/331,32/8183,0.733893754825011,0.835343979496176,0.667416410034379,UBC,1
R-HSA-166166,R-HSA-166166,MyD88-independent TLR4 cascade ,3/331,94/8183,0.739122430475718,0.835343979496176,0.667416410034379,FOS/JUN/UBC,3
R-HSA-937061,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,3/331,94/8183,0.739122430475718,0.835343979496176,0.667416410034379,FOS/JUN/UBC,3
R-HSA-194840,R-HSA-194840,Rho GTPase cycle,4/331,123/8183,0.739367737881204,0.835343979496176,0.667416410034379,RHOA/CDC42/RAC1/RHOB,4
R-HSA-111933,R-HSA-111933,Calmodulin induced events,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,CAMK2B,1
R-HSA-111997,R-HSA-111997,CaM pathway,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,CAMK2B,1
R-HSA-113418,R-HSA-113418,Formation of the Early Elongation Complex,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,POLR2H,1
R-HSA-166658,R-HSA-166658,Complement cascade,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,CFHR1,1
R-HSA-167158,R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,POLR2H,1
R-HSA-4085377,R-HSA-4085377,SUMOylation of SUMOylation proteins,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,SUMO2,1
R-HSA-5655302,R-HSA-5655302,Signaling by FGFR1 in disease,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,HRAS,1
R-HSA-8864260,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/331,33/8183,0.744699934085583,0.835343979496176,0.667416410034379,CDKN1A,1
R-HSA-141424,R-HSA-141424,Amplification of signal from the kinetochores,3/331,95/8183,0.745624745424991,0.835343979496176,0.667416410034379,RPS27/MAD1L1/DYNLL1,3
R-HSA-141444,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,3/331,95/8183,0.745624745424991,0.835343979496176,0.667416410034379,RPS27/MAD1L1/DYNLL1,3
R-HSA-204005,R-HSA-204005,COPII-mediated vesicle transport,2/331,65/8183,0.745779497618135,0.835343979496176,0.667416410034379,FOLR1/TMED10,2
R-HSA-422356,R-HSA-422356,Regulation of insulin secretion,2/331,65/8183,0.745779497618135,0.835343979496176,0.667416410034379,GNG2/GNG5,2
R-HSA-5633007,R-HSA-5633007,Regulation of TP53 Activity,5/331,153/8183,0.747656731452186,0.836452067729168,0.668301741453073,SGK1/AKT3/HDAC1/CHD4/UBC,5
R-HSA-111996,R-HSA-111996,Ca-dependent events,1/331,34/8183,0.755068562529469,0.840750101539905,0.671735749917346,CAMK2B,1
R-HSA-6788656,R-HSA-6788656,Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism,1/331,34/8183,0.755068562529469,0.840750101539905,0.671735749917346,PCBD1,1
R-HSA-6806667,R-HSA-6806667,Metabolism of fat-soluble vitamins,1/331,34/8183,0.755068562529469,0.840750101539905,0.671735749917346,RBP1,1
R-HSA-936440,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,1/331,34/8183,0.755068562529469,0.840750101539905,0.671735749917346,UBC,1
R-HSA-5693532,R-HSA-5693532,DNA Double-Strand Break Repair,5/331,155/8183,0.757751708037948,0.84274156903394,0.673326876588744,HIST1H4C/SUMO2/PRKDC/HIST1H2BK/UBC,5
R-HSA-167172,R-HSA-167172,Transcription of the HIV genome,2/331,67/8183,0.76075916671266,0.844093209709453,0.674406799577896,POLR2H/ELOB,2
R-HSA-418346,R-HSA-418346,Platelet homeostasis,2/331,67/8183,0.76075916671266,0.844093209709453,0.674406799577896,GNG2/GNG5,2
R-HSA-168638,R-HSA-168638,NOD1/2 Signaling Pathway,1/331,35/8183,0.765017305418504,0.8458289926106,0.675793641430974,UBC,1
R-HSA-176033,R-HSA-176033,Interactions of Vpr with host cellular proteins,1/331,35/8183,0.765017305418504,0.8458289926106,0.675793641430974,SLC25A6,1
R-HSA-432720,R-HSA-432720,Lysosome Vesicle Biogenesis,1/331,35/8183,0.765017305418504,0.8458289926106,0.675793641430974,VAMP8,1
R-HSA-5693538,R-HSA-5693538,Homology Directed Repair,4/331,128/8183,0.767091928571379,0.847128483838498,0.676831898474161,HIST1H4C/SUMO2/HIST1H2BK/UBC,4
R-HSA-111465,R-HSA-111465,Apoptotic cleavage of cellular proteins,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,DSP,1
R-HSA-112399,R-HSA-112399,IRS-mediated signalling,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,HRAS,1
R-HSA-383280,R-HSA-383280,Nuclear Receptor transcription pathway,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,NR4A1,1
R-HSA-5674135,R-HSA-5674135,MAP2K and MAPK activation,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,HRAS,1
R-HSA-76046,R-HSA-76046,RNA Polymerase III Transcription Initiation,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,POLR2H,1
R-HSA-8853659,R-HSA-8853659,RET signaling,1/331,36/8183,0.774563116894508,0.84940448907407,0.678650362820382,RET,1
R-HSA-1296071,R-HSA-1296071,Potassium Channels,2/331,71/8183,0.788439668464075,0.862613435183692,0.689203940279741,GNG2/GNG5,2
R-HSA-159236,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,2/331,71/8183,0.788439668464075,0.862613435183692,0.689203940279741,THOC7/SRSF9,2
R-HSA-2428928,R-HSA-2428928,IRS-related events triggered by IGF1R,1/331,38/8183,0.792510376687726,0.865057676523567,0.691156820554643,HRAS,1
R-HSA-3560782,R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/331,38/8183,0.792510376687726,0.865057676523567,0.691156820554643,HEXB,1
R-HSA-199992,R-HSA-199992,trans-Golgi Network Vesicle Budding,2/331,72/8183,0.794905109936068,0.866667376805296,0.692442925931151,FTH1/VAMP8,2
R-HSA-72306,R-HSA-72306,tRNA processing,3/331,104/8183,0.798466787114001,0.867227319573886,0.692890304498077,TRIT1/TRMT112/EPRS,3
R-HSA-110313,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1/331,39/8183,0.800942428905819,0.867227319573886,0.692890304498077,UBC,1
R-HSA-1489509,R-HSA-1489509,DAG and IP3 signaling,1/331,39/8183,0.800942428905819,0.867227319573886,0.692890304498077,CAMK2B,1
R-HSA-165159,R-HSA-165159,mTOR signalling,1/331,39/8183,0.800942428905819,0.867227319573886,0.692890304498077,RHEB,1
R-HSA-2428924,R-HSA-2428924,IGF1R signaling cascade,1/331,39/8183,0.800942428905819,0.867227319573886,0.692890304498077,HRAS,1
R-HSA-512988,R-HSA-512988,Interleukin-3, Interleukin-5 and GM-CSF signaling,1/331,39/8183,0.800942428905819,0.867227319573886,0.692890304498077,UBC,1
R-HSA-1660661,R-HSA-1660661,Sphingolipid de novo biosynthesis,1/331,40/8183,0.80903280906694,0.871917297622348,0.696637465415106,SPTSSA,1
R-HSA-168253,R-HSA-168253,Host Interactions with Influenza Factors,1/331,40/8183,0.80903280906694,0.871917297622348,0.696637465415106,SLC25A6,1
R-HSA-2404192,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/331,40/8183,0.80903280906694,0.871917297622348,0.696637465415106,HRAS,1
R-HSA-6783310,R-HSA-6783310,Fanconi Anemia Pathway,1/331,40/8183,0.80903280906694,0.871917297622348,0.696637465415106,UBC,1
R-HSA-71387,R-HSA-71387,Metabolism of carbohydrates,8/331,253/8183,0.809901948428402,0.871917297622348,0.696637465415106,GYG1/PGAM2/HEXB/AKR1B1/MDH2/IDS/TKT/UBC,8
R-HSA-3108232,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,5/331,167/8183,0.812035528123288,0.873216287091481,0.697675321567113,HIST1H4C/PARK7/SUMO2/HDAC1/DDX17,5
R-HSA-1442490,R-HSA-1442490,Collagen degradation,1/331,41/8183,0.816795321678858,0.874342264797141,0.698574946172707,CTSL,1
R-HSA-74158,R-HSA-74158,RNA Polymerase III Transcription,1/331,41/8183,0.816795321678858,0.874342264797141,0.698574946172707,POLR2H,1
R-HSA-74751,R-HSA-74751,Insulin receptor signalling cascade,1/331,41/8183,0.816795321678858,0.874342264797141,0.698574946172707,HRAS,1
R-HSA-749476,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,1/331,41/8183,0.816795321678858,0.874342264797141,0.698574946172707,POLR2H,1
R-HSA-168325,R-HSA-168325,Viral Messenger RNA Synthesis,1/331,42/8183,0.824243215135539,0.879782575636979,0.702921601944843,POLR2H,1
R-HSA-3214842,R-HSA-3214842,HDMs demethylate histones,1/331,42/8183,0.824243215135539,0.879782575636979,0.702921601944843,HIST1H4C,1
R-HSA-6805567,R-HSA-6805567,Keratinization,2/331,77/8183,0.824679420687317,0.879782575636979,0.702921601944843,KRT12/DSP,2
R-HSA-674695,R-HSA-674695,RNA Polymerase II Pre-transcription Events,2/331,78/8183,0.830148289940861,0.882618159282495,0.705187153745652,POLR2H/ELOB,2
R-HSA-6811558,R-HSA-6811558,PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,2/331,78/8183,0.830148289940861,0.882618159282495,0.705187153745652,HGF/RAC1,2
R-HSA-70326,R-HSA-70326,Glucose metabolism,2/331,78/8183,0.830148289940861,0.882618159282495,0.705187153745652,PGAM2/MDH2,2
R-HSA-69618,R-HSA-69618,Mitotic Spindle Checkpoint,3/331,111/8183,0.832951295966444,0.88326748734547,0.705705948655728,RPS27/MAD1L1/DYNLL1,3
R-HSA-2990846,R-HSA-2990846,SUMOylation,5/331,173/8183,0.835310143125374,0.88326748734547,0.705705948655728,HIST1H4C/PARK7/SUMO2/HDAC1/DDX17,5
R-HSA-983168,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,9/331,290/8183,0.836743328726122,0.88326748734547,0.705705948655728,PSMB9/PSMB8/PSMD6/ELOB/PSMD7/RNF7/RBX1/PSME1/UBC,9
R-HSA-4615885,R-HSA-4615885,SUMOylation of DNA replication proteins,1/331,44/8183,0.8382454907202,0.88326748734547,0.705705948655728,SUMO2,1
R-HSA-5578775,R-HSA-5578775,Ion homeostasis,1/331,44/8183,0.8382454907202,0.88326748734547,0.705705948655728,CAMK2B,1
R-HSA-72202,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,2/331,80/8183,0.840627923669099,0.88326748734547,0.705705948655728,THOC7/SRSF9,2
R-HSA-1483249,R-HSA-1483249,Inositol phosphate metabolism,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,IMPA2,1
R-HSA-167161,R-HSA-167161,HIV Transcription Initiation,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-167162,R-HSA-167162,RNA Polymerase II HIV Promoter Escape,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-2022090,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,CTSL,1
R-HSA-4570464,R-HSA-4570464,SUMOylation of RNA binding proteins,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,SUMO2,1
R-HSA-73776,R-HSA-73776,RNA Polymerase II Promoter Escape,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-73779,R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-75953,R-HSA-75953,RNA Polymerase II Transcription Initiation,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-76042,R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,1/331,45/8183,0.844823785666952,0.88326748734547,0.705705948655728,POLR2H,1
R-HSA-166016,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,3/331,115/8183,0.850291900309013,0.887998858194114,0.709486181259126,FOS/JUN/UBC,3
R-HSA-5620920,R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/331,47/8183,0.85719090155979,0.893223262466064,0.713660333739229,ARF4,1
R-HSA-936837,R-HSA-936837,Ion transport by P-type ATPases,1/331,47/8183,0.85719090155979,0.893223262466064,0.713660333739229,CAMK2B,1
R-HSA-112043,R-HSA-112043,PLC beta mediated events,1/331,48/8183,0.863000858735762,0.898283766772473,0.717703534743902,CAMK2B,1
R-HSA-69473,R-HSA-69473,G2/M DNA damage checkpoint,2/331,85/8183,0.864313782356116,0.898657376357021,0.71800203832302,HIST1H4C/HIST1H2BK,2
R-HSA-112040,R-HSA-112040,G-protein mediated events,1/331,49/8183,0.868575132338523,0.901098870774107,0.719952723883659,CAMK2B,1
R-HSA-1638091,R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,1/331,49/8183,0.868575132338523,0.901098870774107,0.719952723883659,IDS,1
R-HSA-5368286,R-HSA-5368286,Mitochondrial translation initiation,2/331,87/8183,0.872852615743198,0.902095784545821,0.720749230025994,MRPL33/MRPS26,2
R-HSA-5389840,R-HSA-5389840,Mitochondrial translation elongation,2/331,87/8183,0.872852615743198,0.902095784545821,0.720749230025994,MRPL33/MRPS26,2
R-HSA-5419276,R-HSA-5419276,Mitochondrial translation termination,2/331,87/8183,0.872852615743198,0.902095784545821,0.720749230025994,MRPL33/MRPS26,2
R-HSA-3214847,R-HSA-3214847,HATs acetylate histones,3/331,121/8183,0.873366619432897,0.902095784545821,0.720749230025994,HIST1H4C/HIST1H2AC/HIST1H2BK,3
R-HSA-168643,R-HSA-168643,Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways,1/331,51/8183,0.879054375620017,0.906976146587137,0.724648502413457,UBC,1
R-HSA-418594,R-HSA-418594,G alpha (i) signalling events,7/331,248/8183,0.880749260342696,0.907730638121247,0.725251319987364,RGS7/RBP1/GNG2/PSAP/NPW/CAMK2B/GNG5,7
R-HSA-3247509,R-HSA-3247509,Chromatin modifying enzymes,7/331,249/8183,0.883202878921583,0.908076980574001,0.725528037892961,HIST1H4C/HIST1H2AC/H2AFZ/HDAC1/COPRS/CHD4/HIST1H2BK,7
R-HSA-4839726,R-HSA-4839726,Chromatin organization,7/331,249/8183,0.883202878921583,0.908076980574001,0.725528037892961,HIST1H4C/HIST1H2AC/H2AFZ/HDAC1/COPRS/CHD4/HIST1H2BK,7
R-HSA-186797,R-HSA-186797,Signaling by PDGF,1/331,52/8183,0.883977273021613,0.908076980574001,0.725528037892961,HRAS,1
R-HSA-193648,R-HSA-193648,NRAGE signals death through JNK,1/331,53/8183,0.888700372594832,0.911934369263978,0.728609983264884,RAC1,1
R-HSA-375165,R-HSA-375165,NCAM signaling for neurite out-growth,1/331,54/8183,0.893231759639249,0.914591649543666,0.730733075677418,HRAS,1
R-HSA-425366,R-HSA-425366,Transport of bile salts and organic acids, metal ions and amine compounds,1/331,54/8183,0.893231759639249,0.914591649543666,0.730733075677418,BSG,1
R-HSA-5368287,R-HSA-5368287,Mitochondrial translation,2/331,93/8183,0.895590928098079,0.916011568152433,0.731867550820192,MRPL33/MRPS26,2
R-HSA-162599,R-HSA-162599,Late Phase of HIV Life Cycle,3/331,132/8183,0.907627364716568,0.927315593886125,0.740899150328058,POLR2H/ELOB/UBC,3
R-HSA-9033241,R-HSA-9033241,Peroxisomal protein import,1/331,58/8183,0.909590742194472,0.92831471196879,0.741697417653017,UBC,1
R-HSA-168928,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/331,61/8183,0.920197373007195,0.938123295857985,0.749534201071024,UBC,1
R-HSA-3214841,R-HSA-3214841,PKMTs methylate histone lysines,1/331,62/8183,0.923449610083607,0.939405542871229,0.750558680470364,HIST1H4C,1
R-HSA-70171,R-HSA-70171,Glycolysis,1/331,62/8183,0.923449610083607,0.939405542871229,0.750558680470364,PGAM2,1
R-HSA-196849,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,2/331,103/8183,0.92527864854651,0.94025079496312,0.751234013184301,CYB5A/GSTO1,2
R-HSA-1483206,R-HSA-1483206,Glycerophospholipid biosynthesis,2/331,104/8183,0.927765155633422,0.94176161272272,0.752441114199066,MFSD2A/AGPAT2,2
R-HSA-2187338,R-HSA-2187338,Visual phototransduction,1/331,65/8183,0.93243458783913,0.943301968240648,0.753671815054267,RBP1,1
R-HSA-400253,R-HSA-400253,Circadian Clock,1/331,65/8183,0.93243458783913,0.943301968240648,0.753671815054267,UBC,1
R-HSA-162587,R-HSA-162587,HIV Life Cycle,3/331,143/8183,0.933288146921745,0.943301968240648,0.753671815054267,POLR2H/ELOB/UBC,3
R-HSA-8978868,R-HSA-8978868,Fatty acid metabolism,3/331,143/8183,0.933288146921745,0.943301968240648,0.753671815054267,PON3/PON2/PTGES3,3
R-HSA-5685942,R-HSA-5685942,HDR through Homologous Recombination (HRR),1/331,67/8183,0.937832355639448,0.946878970002529,0.756529739134885,UBC,1
R-HSA-1630316,R-HSA-1630316,Glycosaminoglycan metabolism,2/331,109/8183,0.939069924975685,0.947113350457276,0.756717002544365,HEXB/IDS,2
R-HSA-6794362,R-HSA-6794362,Protein-protein interactions at synapses,1/331,69/8183,0.942800096889552,0.949858493336854,0.758910294709856,SLITRK6,1
R-HSA-381340,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/331,74/8183,0.953555674840977,0.9577609046586,0.76522409971047,CEBPD,1
R-HSA-6807505,R-HSA-6807505,RNA polymerase II transcribes snRNA genes,1/331,74/8183,0.953555674840977,0.9577609046586,0.76522409971047,POLR2H,1
R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,3/331,155/8183,0.953693979373426,0.9577609046586,0.76522409971047,CYB5A/RBP1/GSTO1,3
R-HSA-3108214,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/331,75/8183,0.955451478469987,0.958504039104076,0.765817843289099,SUMO2,1
R-HSA-6804756,R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,1/331,89/8183,0.975157080733125,0.977231883032557,0.780780865312636,UBC,1
R-HSA-3781865,R-HSA-3781865,Diseases of glycosylation,1/331,124/8183,0.994256707531051,0.99466962203662,0.794713129686204,HEXB,1
R-HSA-1483257,R-HSA-1483257,Phospholipid metabolism,2/331,177/8183,0.99466962203662,0.99466962203662,0.794713129686204,MFSD2A/AGPAT2,2
